<!DOCTYPE html> 
<html> 
<head> <title>An updated meta-analysis on the eﬀectiveness of neurofeedback in child ADHD: design choices that
really matter.</title> 
<meta charset="UTF-8" /> 
<meta name="generator" content="TeX4ht (http://www.cse.ohio-state.edu/~gurari/TeX4ht/)" /> 
<link rel="stylesheet" type="text/css" href="manuscript.css" /> 
<script type="text/javascript" 
src="http://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML" 
></script> 
<style type="text/css"> 
.MathJax_MathML {text-indent: 0;} 
</style> 
</head><body 
>
   <div class="maketitle">
                                                                                            
                                                                                            
                                                                                            
                                                                                            

<h2 class="titleHead">An updated meta-analysis on the eﬀectiveness of
neurofeedback in child ADHD: design choices that really
matter.</h2>
<div class="author" ></div><br />
<div class="date" ><span 
class="ecss-1440">August 30, 2018</span></div>
   </div>Aurore Bussalb<!--l. 8--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>a</mi></mrow></msup 
></math>, PhD
student, Marco Congedo<!--l. 8--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>b</mi></mrow></msup 
></math>,
PhD, Quentin Barthelemy<!--l. 8--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>a</mi></mrow></msup 
></math>,
PhD, David Ojeda<!--l. 8--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>a</mi></mrow></msup 
></math>, PhD,
Eric Acquaviva<!--l. 9--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>c</mi></mrow></msup 
></math>, MD,
PhD, Richard Delorme<!--l. 9--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>c</mi></mrow></msup 
></math>,
MD, PhD, Louis Mayaud<!--l. 9--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>a</mi></mrow></msup 
></math>,
D.Phil.
<!--l. 11--><p class="noindent" ><!--l. 11--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>a</mi></mrow></msup 
></math>: Mensia
Technolgies, Paris France <br 
class="newline" /><!--l. 12--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>b</mi></mrow></msup 
></math>:
GIPSA-Lab, Grenoble France <br 
class="newline" /><!--l. 13--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>c</mi></mrow></msup 
></math>:
Hôpital Robert Debré, Paris France <br 
class="newline" />
</p><!--l. 15--><p class="noindent" ><span 
class="ecsx-1200">Full postal address </span><br 
class="newline" />Mensia Technologies <br 
class="newline" />Plateforme d’innovation Boucicaut <br 
class="newline" />130 rue de Lourmel <br 
class="newline" />75015 Paris - France <br 
class="newline" />Aurore Bussalb’s e-mail: aurore.bussalb@mensiatech.com <br 
class="newline" />Louis Mayaud’s e-mail: lm@mensiatech.com
</p><!--l. 23--><p class="indent" >   A. Bussalb, Q. Barthelemy, D. Ojeda, and L. Mayaud work for Mensia Technologies. M. Congedo
served as an advisor for Mensia Technologies when this work was conducted.
</p><!--l. 26--><p class="indent" >   This research was conducted as part of a PhD thesis funded by Mensia Technologies and the
Association Nationale Recherche et Technologie (ANRT) as well as the EU H2020 NEWROFEED
grant.
</p><!--l. 29--><p class="indent" >   Number of words: 5701 <br 
class="newline" />Number of ﬁgures: 4
                                                                                            
                                                                                            
</p>
   <div 
class="abstract" 
>
<div class="center" 
>
<!--l. 13--><p class="noindent" >
</p><!--l. 13--><p class="noindent" ><span 
class="ecsx-1095">Abstract</span></p></div>
      <!--l. 6--><p class="noindent" ><span 
class="ecss-1095">Numerous trials and several meta-analysis have been published on the eﬃcacy of Neurofeedback</span>
      <span 
class="ecss-1095">(NFB) applied to Attention Deﬁcit Hyperactivity Disorder (ADHD) in children and adolescents</span>
      <span 
class="ecss-1095">with inconsistent ﬁndings.</span>
      </p><!--l. 9--><p class="indent" >   <span 
class="ecss-1095">This  work  replicated  the  latest  meta-analysis  on  that  topic  (2016)  and,  by  doing  so,</span>
      <span 
class="ecss-1095">benchmarked methodological choices originally made and later challenged.</span>
      </p><!--l. 12--><p class="indent" >   <span 
class="ecss-1095">Furthermore, the meta-analysis was updated including two recently published randomized</span>
      <span 
class="ecss-1095">control trials.</span>
      </p><!--l. 14--><p class="indent" >   <span 
class="ecss-1095">This process revealed the heterogeneity of studies included in past meta-analysis, which</span>
      <span 
class="ecss-1095">questions the reliability of their results.</span>
      </p><!--l. 17--><p class="indent" >   <span 
class="ecss-1095">The analysis was therefore completed with a novel method: the systematic analysis of biases</span>
      <span 
class="ecss-1095">(SAOB) that takes advantage of studies technical and methodological heterogeneity rather</span>
      <span 
class="ecss-1095">than suﬀering from it.</span>
      </p><!--l. 20--><p class="indent" >   <span 
class="ecss-1095">The SAOB was performed on k = 31 studies meeting the same inclusion criteria as for the</span>
      <span 
class="ecss-1095">update of the meta-analysis (but the requirement for a control arm).</span>
      </p><!--l. 22--><p class="indent" >   <span 
class="ecss-1095">The update of the most recent meta-analysis with two new publications conﬁrmed the</span>
      <span 
class="ecss-1095">results originally obtained: eﬀect sizes were signiﬁcant when clinical scales of ADHD were rated</span>
      <span 
class="ecss-1095">by parents (p-value = 0.0017) but not when teachers did (considered as probably blind, p-value</span>
      <span 
class="ecss-1095">= 0.14).</span>
      </p><!--l. 26--><p class="indent" >   <span 
class="ecss-1095">Also,  signiﬁcant  improvements  were  conﬁrmed  for  the  subset  of  studies  meeting  the</span>
      <span 
class="ecss-1095">deﬁnition of &#x0022;standard NFB protocols&#x0022; even when clinical outcomes were observed by probably</span>
      <span 
class="ecss-1095">blind raters (p-value = 0.043, k = 4 studies).</span>
      </p><!--l. 29--><p class="indent" >   <span 
class="ecss-1095">The SAOB identiﬁed 3 elements that might have an impact on NFB eﬃcacy: ﬁrst, a</span>
      <span 
class="ecss-1095">more intensive treatment was associated with higher eﬃcacy; second, high-end EEG systems</span>
      <span 
class="ecss-1095">improved the eﬀectiveness of NFB in ADHD; third, the person assessing the symptoms changes</span>
      <span 
class="ecss-1095">during trials had an impact on results: teachers seemed to score less improvement.</span>
      </p><!--l. 33--><p class="indent" >   <span 
class="ecss-1095">In conclusion, more than replicating previous ﬁndings, we introduced here a new way to</span>
      <span 
class="ecss-1095">look into the heterogeneity of clinical trials.</span>
                                                                                            
                                                                                            
      </p><!--l. 16--><p class="noindent" ><span 
class="ecss-1095">keywords: ADHD, neurofeedback, meta-analysis, analysis of bias</span>
</p>
</div>
   <h3 class="sectionHead"><span class="titlemark">1   </span> <a 
 id="x1-10001"></a>Introduction</h3>
<!--l. 8--><p class="noindent" ><a 
href="#glo:adhd">Attention Deﬁcit/Hyperactivity Disorder (ADHD)</a> is a common child psychiatric disorder characterized by
impaired attention and/or hyperactivity/impulsivity. Symptoms may persist in adulthood with clinical
signiﬁcance, which makes <a 
href="#glo:adhd">ADHD</a> a life-long problem for many patients [<a 
href="#XFaraone2006">Faraone et al.</a>, <a 
href="#XFaraone2006">2006</a>]. The
prevalence of <a 
href="#glo:adhd">ADHD</a> is about 5% in school-aged children yielding to an estimated 2.5 millions of children in
Europe [<a 
href="#XDSM-5">The American Psychiatric Association</a>, <a 
href="#XDSM-5">2013</a>]. <a 
href="#glo:adhd">ADHD</a> impacts children’s well-being
with many of them suﬀering from low self esteem [<a 
href="#XShaw2005">Shaw-Zirt et al.</a>, <a 
href="#XShaw2005">2005</a>] and underachieve
at school [<a 
href="#XBarry2002">Barry et al.</a>, <a 
href="#XBarry2002">2002</a>]. Parents are equally aﬀected by this situation [<a 
href="#XHarpin2005">Harpin</a>, <a 
href="#XHarpin2005">2005</a>].
Besides <a 
href="#glo:adhd">ADHD</a> has a ﬁnancial impact: a survey of 2013 in the Netherlands estimated at between
<!--l. 14--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>9</mn><mo 
class="MathClass-punc">,</mo> <mn>8</mn><mn>6</mn><mn>0</mn></math> and
<!--l. 14--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>1</mn><mn>4</mn><mo 
class="MathClass-punc">,</mo> <mn>4</mn><mn>8</mn><mn>3</mn></math>the
costs related to <a 
href="#glo:adhd">ADHD</a> per patient annually [<a 
href="#Xle2014">Le et al.</a>, <a 
href="#Xle2014">2014</a>].
</p><!--l. 16--><p class="indent" >   The diagnosis of <a 
href="#glo:adhd">ADHD</a> primarily relies on questionnaire-based clinical evaluation [<a 
href="#XDSM-5">The American
Psychiatric Association</a>, <a 
href="#XDSM-5">2013</a>], which can be supported with objective assessment metrics of executive
function such as the <a 
href="#glo:tova">Test of Variables of Attention (TOVA)</a> [<a 
href="#XForbes1998">Forbes</a>, <a 
href="#XForbes1998">1998</a>], the <a 
href="#glo:cpt">Continuous Performance
Test (CPT)</a> [<a 
href="#XBarkley1991">Barkley</a>, <a 
href="#XBarkley1991">1991</a>], and the <a 
href="#glo:sart">Sustained Attention to Response Task (SART)</a> [<a 
href="#XRobertson1997">Robertson
et al.</a>, <a 
href="#XRobertson1997">1997</a>]. Conversely, objective markers of brain function using <a 
href="#glo:eeg">Electroencephalogram (EEG)</a>,
<a 
href="#glo:fmri">functional Magnetic Resonance Imaging (fMRI)</a>, or <a 
href="#glo:pet">Positron Emission Tomography (PET)</a> could not
successfully improve diagnosis [<a 
href="#XNeba">Neba Health</a>] at the individual level but proved signiﬁcantly diﬀerent at the
population level. For instance, <a 
href="#glo:adhd">ADHD</a> patients were found to show an increase in theta waves (4-8Hz) in
the frontal area whereas there are less beta waves (12-32Hz) and <a 
href="#glo:smr">Sensorimotor Rhythm (SMR)</a>
(13-15Hz) in the central area [<a 
href="#XMonastra2005">Monastra</a>, <a 
href="#XMonastra2005">2005</a>; <a 
href="#XMatouvsek1984">Matoušek et al.</a>, <a 
href="#XMatouvsek1984">1984</a>; <a 
href="#XJanzen1995">Janzen et al.</a>, <a 
href="#XJanzen1995">1995</a>; <a 
href="#Xloo2017">Loo
et al.</a>, <a 
href="#Xloo2017">2017</a>].
</p><!--l. 24--><p class="indent" >   Among all existing treatments, the most widely used is psychostimulants, which have been proven to be
eﬃcacious [<a 
href="#XTaylor2014">Taylor</a>, <a 
href="#XTaylor2014">2014</a>; <a 
href="#XStorebo2015">Storebo et al.</a>, <a 
href="#XStorebo2015">2015</a>]. However, its long-term eﬀectiveness is still
an active area of research [<a 
href="#XDuPaul1998">DuPaul</a>, <a 
href="#XDuPaul1998">1998</a>; <a 
href="#XSwanson2001">Swanson et al.</a>, <a 
href="#XSwanson2001">2001</a>; <a 
href="#XJensen1999">Jensen</a>, <a 
href="#XJensen1999">1999</a>]. Moreover,
<a 
href="#glo:adhd">ADHD</a> children under medication commonly suﬀer from mild side eﬀects such as loss of appetite
and sleep problems even though only few serious adverse events have been reported [<a 
href="#XStorebo2015">Storebo
                                                                                            
                                                                                            
et al.</a>, <a 
href="#XStorebo2015">2015</a>; <a 
href="#XCooper2011">Cooper et al.</a>, <a 
href="#XCooper2011">2011</a>]. These drawbacks make some parents and clinicians reluctant to
choose such treatment turning them to drug-free alternatives such as dietary changes [<a 
href="#XBelanger2009">Bélanger
et al.</a>, <a 
href="#XBelanger2009">2009</a>] and behavioral therapy, which have been proven less eﬃcacious [<a 
href="#XSonuga-Barke2013">Sonuga-Barke
et al.</a>, <a 
href="#XSonuga-Barke2013">2013</a>].
</p><!--l. 32--><p class="indent" >   <a 
href="#glo:nfb">Neurofeedback (NFB)</a> is a noninvasive technique aiming at the reduction of <a 
href="#glo:adhd">ADHD</a> symptoms [<a 
href="#XArns2015">Arns
et al.</a>, <a 
href="#XArns2015">2015</a>; <a 
href="#XSteffert2010">Steﬀert and Steﬀert</a>, <a 
href="#XSteffert2010">2010</a>; <a 
href="#XMarzbani2016">Marzbani et al.</a>, <a 
href="#XMarzbani2016">2016</a>]. It is a self-paced brain neuromodulation
technique that represents one’s brain activity in real-time using auditory or visual modulations, on which
learning paradigms can be applied such as operant conditioning [<a 
href="#XReynolds1975">Reynolds</a>, <a 
href="#XReynolds1975">1975</a>] or voluntary control. To
deliver this intervention, neurophysiological time series must be recorded and analyzed in real-time and
implemented in serious games leveraging learning paradigms [<a 
href="#XWang2010">Wang et al.</a>, <a 
href="#XWang2010">2010</a>]. To that eﬀect, recorded
brain signals are analyzed to extract a real time representation of the activity of a population of neurons
involved in attentional networks, which is translated into visual or auditory cues. The sensory
feedback constitutes the rewards mechanism promoting learning using operant conditioning
protocol [<a 
href="#XSherlin2011">Sherlin et al.</a>, <a 
href="#XSherlin2011">2011</a>]. Operant conditioning enables neural plasticity supporting the child
in the task repetition [<a 
href="#XSkinner1961">Skinner</a>, <a 
href="#XSkinner1961">1961</a>] leading to lasting neuronal reorganization [<a 
href="#XVanDoren2017">Van Doren
et al.</a>, <a 
href="#XVanDoren2017">2017</a>].
</p><!--l. 43--><p class="indent" >   In case of <a 
href="#glo:adhd">ADHD</a>, several <a 
href="#glo:nfb">NFB</a> protocols have been proposed and investigated to decrease the
symptoms: </p>
      <ul class="itemize1">
      <li class="itemize">protocols based on frequency-band training: a child can be asked to enhance his <a 
href="#glo:smr">SMR</a> while
      suppressing theta or beta [<a 
href="#XLubar1976">Lubar and Shouse</a>, <a 
href="#XLubar1976">1976</a>], or enhance beta while suppressing theta
      (this scenario is known as <a 
href="#glo:tbr">Theta Beta Ratio (TBR)</a>) [<a 
href="#XArns2013">Arns et al.</a>, <a 
href="#XArns2013">2013</a>];
      </li>
      <li class="itemize">protocol based on the <a 
href="#glo:scp">Slow Cortical Potentials (SCPs)</a> training consisting in the regulation
      of cortical excitation thresholds by focusing on activity generated by external cues (similar to
      <a 
href="#glo:erp">Event-Related Potentials (ERPs)</a>) [<a 
href="#XHeinrich2004">Heinrich et al.</a>, <a 
href="#XHeinrich2004">2004</a>; <a 
href="#XBanaschewski2007">Banaschewski and Brandeis</a>, <a 
href="#XBanaschewski2007">2007</a>];
      </li>
      <li class="itemize">protocol based on <a 
href="#glo:erp">ERPs</a> (P300) [<a 
href="#XFouillen2017">Fouillen et al.</a>, <a 
href="#XFouillen2017">2017</a>]: children have to focus on external cues
      leading to a reduced P300 amplitude so it can be considered as a speciﬁc neurophysiological
      marker of selective attention [<a 
href="#XRolandLeBouedec">Bouëdec</a>, <a 
href="#XRolandLeBouedec">2017</a>].</li></ul>
<!--l. 56--><p class="indent" >   Shortly after the discovery of the brain’s electric activity by <a 
href="#XBerger1929">Berger</a> [<a 
href="#XBerger1929">1929</a>], <a 
href="#XDurup1935">Durup and Fessard</a> [<a 
href="#XDurup1935">1935</a>]
proved it could be voluntarily modulated leading a series of ﬁnding on the self-regulation of brain activity.
                                                                                            
                                                                                            
The ﬁrst indication of its therapeutic potential came forty years later when <a 
href="#XSterman1974">Sterman et al.</a> [<a 
href="#XSterman1974">1974</a>]
serendipitously found the training of <a 
href="#glo:smr">SMR</a> activity to reduce the incidence of epileptic crisis in
kerozen-exposed cats. The technique, then known as <a 
href="#glo:nfb">NFB</a> quickly became investigated in various
ﬁelds of neuropsychiatry including, most notably, <a 
href="#glo:adhd">ADHD</a> and resulting in a relatively large
body of scientiﬁc literature [<a 
href="#XLubar1976">Lubar and Shouse</a>, <a 
href="#XLubar1976">1976</a>; <a 
href="#XRossiter1995">Rossiter and La Vaque</a>, <a 
href="#XRossiter1995">1995</a>; <a 
href="#XLinden1996">Linden
et al.</a>, <a 
href="#XLinden1996">1996</a>; <a 
href="#XMaurizio2014">Maurizio et al.</a>, <a 
href="#XMaurizio2014">2014</a>]. Subsequently, its eﬃcacy on the core symptoms of <a 
href="#glo:adhd">ADHD</a>
(inattention, hyperactivity, and impulsivity) has been subject to several meta-analytic studies [<a 
href="#XLoo2005">Loo and
Barkley</a>, <a 
href="#XLoo2005">2005</a>; <a 
href="#XLofthouse2012">Lofthouse et al.</a>, <a 
href="#XLofthouse2012">2012</a>; <a 
href="#XArns2009">Arns et al.</a>, <a 
href="#XArns2009">2009</a>; <a 
href="#XMicoulaud2014">Micoulaud-Franchi et al.</a>, <a 
href="#XMicoulaud2014">2014</a>; <a 
href="#XSonuga-Barke2013">Sonuga-Barke
et al.</a>, <a 
href="#XSonuga-Barke2013">2013</a>].
</p><!--l. 65--><p class="indent" >   The most recent meta-analysis solely on the eﬃcacy of <a 
href="#glo:nfb">NFB</a> has been conducted by <a 
href="#XCortese2016">Cortese
et al.</a> [<a 
href="#XCortese2016">2016</a>] where 13 studies were included. Although only <a 
href="#glo:rct">Randomized Controlled Trials (RCTs)</a> were
selected, the authors of this meta-analysis made some choices that have since been debated by the
community. Speciﬁcally, <a 
href="#XMicoulaud2016">Micoulaud-Franchi et al.</a> [<a 
href="#XMicoulaud2016">2016</a>] criticized the use of an uncommon behavioral
scale provided by <a 
href="#XSteiner2014">Steiner et al.</a> [<a 
href="#XSteiner2014">2014</a>] for the teachers’ assessments and the inclusion of a pilot study
carried out by <a 
href="#XArnold2014">Arnold et al.</a> [<a 
href="#XArnold2014">2014</a>].
</p><!--l. 71--><p class="indent" >   Finally, because of the publication of new <a 
href="#glo:rct">RCTs</a> meeting <a 
href="#XCortese2016">Cortese et al.</a>’s inclusion criteria, it was
decided to update his work and take the opportunity to investigate some choices that later proved
controversial. Eventually, we extended the analysis with a novel method: the <a 
href="#glo:saob">Systematic Analysis of Biases
(SAOB)</a> that takes advantage of studies technical and methodological high heterogeneity rather than
suﬀering from it. Indeed, the <a 
href="#glo:nfb">NFB</a> domain is characterized by a clinical literature that is tremendously
heterogeneous: studies diﬀer methodologically (randomization and presence of a blind assessor for instance)
but also on the <a 
href="#glo:nfb">NFB</a> implementation (number of sessions, session and treatment length, and type of
protocol for instance) as well as on the acquisition and pre-processing of the <a 
href="#glo:eeg">EEG</a>. Since methodological
and technical implementations of studies may inﬂuence their outcomes, we suggest here to identify which
of the factors independently inﬂuence the reported <a 
href="#glo:es">Eﬀect Size (ES)</a> with the use of adequate statistical
tools.
</p><!--l. 6--><p class="noindent" >
</p>
   <h3 class="sectionHead"><span class="titlemark">2   </span> <a 
 id="x1-20002"></a>Materials and Methods</h3>
                                                                                            
                                                                                            
<!--l. 8--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">2.1   </span> <a 
 id="x1-30002.1"></a>Studies selection</h4>
<!--l. 10--><p class="noindent" >Search terms described in Supplemental Materials [<a 
href="#XSupplementalmaterial">Bussalb</a>, <a 
href="#XSupplementalmaterial">2018b</a>] were entered in Pubmed and studies
included in previous meta-analysis were identiﬁed. Among these studies, those that satisﬁed each of these
points were selected: </p>
      <ul class="itemize1">
      <li class="itemize">studies have to assess <a 
href="#glo:nfb">NFB</a> eﬃcacy;
      </li>
      <li class="itemize">subjects   must   be   diagnosed   <a 
href="#glo:adhd">ADHD</a>  based   on   DSM-IV  [<a 
href="#XDSM-4">The   American   Psychiatric
      Association</a>, <a 
href="#XDSM-4">2000</a>], DSM-V [<a 
href="#XDSM-5">The American Psychiatric Association</a>, <a 
href="#XDSM-5">2013</a>], ICD-10 [<a 
href="#XICD101993">World
      Health Organization</a>, <a 
href="#XICD101993">1993</a>] criteria or according to an expert psychiatrist;
      </li>
      <li class="itemize">studies have to be written in English, German or French;
      </li>
      <li class="itemize">studies have to include at least 8 subjects in each group;
      </li>
      <li class="itemize">subjects must be younger than 25 years old;
      </li>
      <li class="itemize">publications (or subsequently their corresponding author) have to disclose suﬃcient data to
      compute required metrics for the following analysis.</li></ul>
<!--l. 23--><p class="noindent" >The studies satisfying all these points were included in the <a 
href="#glo:saob">SAOB</a>. To replicate and update <a 
href="#XCortese2016">Cortese et al.</a>’s
meta-analysis, we then applied the inclusion criteria of this meta-analysis to the selected studies (the main
diﬀerence being the presence of an active control).
</p><!--l. 27--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">2.2   </span> <a 
 id="x1-40002.2"></a>Outcome deﬁnition</h4>
<!--l. 29--><p class="noindent" >In included studies, the severity of <a 
href="#glo:adhd">ADHD</a> symptoms have been assessed by parents and, when available, by
teachers. <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>] and <a 
href="#XMicoulaud2014">Micoulaud-Franchi et al.</a> [<a 
href="#XMicoulaud2014">2014</a>] deﬁned parents as <a 
href="#glo:mprox">Most Proximal
                                                                                            
                                                                                            
(MPROX)</a> raters who were not blind to the treatment of their child, as opposed to teachers who
were considered as <a 
href="#glo:pblind">Probably Blind (PBLIND)</a> raters. This distinction is meant to assess the
amplitude of the placebo eﬀect where it is hypothesized that teachers who are presumed more blind
to the intervention are less inﬂuenced in their assessment by their perception of it. Eﬃcacy
of <a 
href="#glo:nfb">NFB</a> was given for the following outcomes on clinical scales when available: inattention,
hyperactivity/impulsivity, and total scores. The factors analysis was performed using the total score
only.
</p><!--l. 37--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">2.3   </span> <a 
 id="x1-50002.3"></a>Meta-analysis</h4>
<!--l. 39--><p class="noindent" >Meta-analysis is typically used to aggregate results from diﬀerent clinical investigations and oﬀer a
consolidated state of evidence. To aggregate results from diﬀerent studies, it is necessary to assume some
level of homogeneity in their design relative to the inclusion criteria, the speciﬁcity intervention, the
presence and the type of control (active, semi-active, or non-active). Because studies occasionally
use slight variations of a clinical scales and because of the clinical heterogeneity of patients
and control, the scores are standardized before being pooled. The between <a 
href="#glo:es">ES</a> is one of such
standardized metrics, which we implemented in this paper as described in the Supplemental Materials
[<a 
href="#XSupplementalmaterial">Bussalb</a>, <a 
href="#XSupplementalmaterial">2018b</a>].
</p><!--l. 47--><p class="indent" >   The work was carried with an open-source Python package developed for this work that oﬀers a more
transparent approach to the choice or parameters and increases replicability. This package was benchmark
against RevMan v5.3 [<a 
href="#XRevMan">Cochrane Collaboration</a>, <a 
href="#XRevMan">2011</a>] by replicating <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>]’s work and
obtaining the same results. The code is made fully available on a GitHub repository [<a 
href="#XBussalb2018">Bussalb</a>, <a 
href="#XBussalb2018">2018a</a>]
including raw data for everyone to review its implementation, update it, or use it for their own
projects.
</p><!--l. 53--><p class="indent" >   Before updating the <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>]’s work with recently published studies ﬁtting with their
inclusion criteria [<a 
href="#XStrehl2017">Strehl et al.</a>, <a 
href="#XStrehl2017">2017</a>; <a 
href="#XBaumeister2016">Baumeister et al.</a>, <a 
href="#XBaumeister2016">2016</a>], we decided to run a sensitivity analysis
investigating choices that later proved controversial [<a 
href="#XMicoulaud2016">Micoulaud-Franchi et al.</a>, <a 
href="#XMicoulaud2016">2016</a>]. Altogether, the
changes investigated in our update included the following: </p>
      <ul class="itemize1">
      <li class="itemize">the <a 
href="#glo:es">ES</a> of <a 
href="#XArnold2014">Arnold et al.</a>’s study was computed from the post-test clinical values taken after
      the completion of the 40 sessions at the opposite of <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>]’s report which used
                                                                                            
                                                                                            
      the results after only 12 sessions because the end point values were not available at the time
      of his study;
      </li>
      <li class="itemize">the  <a 
href="#glo:es">ES</a>  computed  from  teachers’  assessments  reported  by  <a 
href="#XSteiner2014">Steiner  et al.</a> [<a 
href="#XSteiner2014">2014</a>]  relied
      on  the  BOSS  Classroom  Observation  [<a 
href="#XShapiro2010">Shapiro</a>, <a 
href="#XShapiro2010">2010</a>].  This  was  an  atypical  scale  to
      quantify <a 
href="#glo:adhd">ADHD</a> symptoms since the Conners Rating Scale Revised [<a 
href="#XConners1998">Conners et al.</a>, <a 
href="#XConners1998">1998</a>]
      [<a 
href="#XChristiansen2014">Christiansen  et al.</a>, <a 
href="#XChristiansen2014">2014</a>; <a 
href="#XBluschke2016">Bluschke  et al.</a>, <a 
href="#XBluschke2016">2016</a>],  whose  metrics  is  well-deﬁned  [<a 
href="#XCollett2003">Collett
      et al.</a>, <a 
href="#XCollett2003">2003</a>; <a 
href="#XEpstein2012">Epstein and Weiss</a>, <a 
href="#XEpstein2012">2012</a>], was more often used and available in this study. Thus,
      we decided to compute the <a 
href="#glo:es">ES</a> based on the results from the Conners-3, which was used in
      this study to compute the <a 
href="#glo:es">ES</a> for the parents’ ratings.</li></ul>
<!--l. 69--><p class="indent" >   As initially suggested, we also performed two subgroups analysis with the two choices described above:
ﬁrst, only with studies following standard protocol as deﬁned by <a 
href="#XArns2014">Arns et al.</a> [<a 
href="#XArns2014">2014</a>] and then with studies
whose participants took low-dose or no medication during the trial.
</p><!--l. 73--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">2.4   </span> <a 
 id="x1-60002.4"></a>Identify factors inﬂuencing the Neurofeedback</h4>
<!--l. 75--><p class="noindent" >While revisiting the meta-analysis, it became apparent that the studies pooled together where highly
heterogeneous in terms of methodological and practical implementation as pointed out by <a 
href="#XAlkoby2017">Alkoby
et al.</a> [<a 
href="#XAlkoby2017">2017</a>]. For instance, all <a 
href="#glo:nfb">NFB</a> interventions were pooled together irrelevant to the quality of the
acquisition, the level excerted on real time data quality, and the trained neuromarker. Likewise, the
methodological implementations varied signiﬁcantly, requiring the ’subgroup’ analysis (low
drug, standard protocols) that are somewhat arbitrary. To circumvent these limitations, we
implemented a novel approach: the <a 
href="#glo:saob">SAOB</a>. In this setting, the within-<a 
href="#glo:es">ES</a> of each intervention
was considered as a dependent variable that methodological and technical biases explained
using standard statistical tools. The results of such analysis should enable us to identify known
methodological biases (e.g. blind assessments negatively associated with <a 
href="#glo:es">ES</a>) and possibly
technical factors (e.g. a good control on real time data quality inﬂuences positively the treatment
outcome).
</p><!--l. 86--><p class="noindent" >
                                                                                            
                                                                                            
</p>
   <h5 class="subsubsectionHead"><span class="titlemark">2.4.1   </span> <a 
 id="x1-70002.4.1"></a>Identify and pre-process factors</h5>
<!--l. 88--><p class="noindent" >We classiﬁed the factors inﬂuencing the eﬃcacy of <a 
href="#glo:nfb">NFB</a> in 5 categories: methodological, technical,
demographics, and quality of the signal acquisition. Factors were chosen based on what was typically
reported in the literature, presumed to inﬂuence <a 
href="#glo:es">ES</a>, and categorized as follow:
</p>
      <ul class="itemize1">
      <li class="itemize"><span 
class="ecsi-1200">the signal quality</span>: correction of ocular and generic (amplitude based) artifacts correction;
      </li>
      <li class="itemize"><span 
class="ecsi-1200">the population</span>: the psychostimulants intake during <a 
href="#glo:nfb">NFB</a> treatment and the age bounds of
      children included;
      </li>
      <li class="itemize"><span 
class="ecsi-1200">the methodological biases</span>: the presence of a control group, the blinding of assessors, the
      randomization of subjects, and the approval of the study by an <a 
href="#glo:irb">Institutional Review Board
      (IRB)</a>;
      </li>
      <li class="itemize"><span 
class="ecsi-1200">the </span><a 
href="#glo:nfb"><span 
class="ecsi-1200">NFB</span></a> <span 
class="ecsi-1200">implementation</span>: the protocol used (<a 
href="#glo:scp">SCP</a>, <a 
href="#glo:smr">SMR</a>, theta up, beta up in central areas,
      theta down), the presence of a transfer phase during <a 
href="#glo:nfb">NFB</a> training, the possibility to train at
      home or at school with a transfer card reminding of the <a 
href="#glo:nfb">NFB</a> session, the type of thresholding
      reward, the number of <a 
href="#glo:nfb">NFB</a> sessions, the sessions frequency, and the sessions and treatment
      lengths;
      </li>
      <li class="itemize"><span 
class="ecsi-1200">the acquisition quality</span>: the presence of one or more active electrodes and the <a 
href="#glo:eeg">EEG</a> quality. This last
      factor was coded as an indicator between 1 and 3. To get an indicator equal to three, the following
      three points had to be satisﬁed:
           <dl class="description"><dt class="description">
      <span 
class="ecso-1200">the type of electrodes used</span> </dt><dd 
class="description">: <a 
href="#glo:agcl">Silver Chloride (AgCl)</a>/Gel and <a 
href="#glo:au">Gold (Au)</a>/Gel;
           </dd><dt class="description">
      <span 
class="ecso-1200">the use of impedance mode</span> </dt><dd 
class="description">: a check of electrode contacts quality trough the ampliﬁer
           impedance acquisition mode so that inter-electrode impedance are smaller than <!--l. 110--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>4</mn><mn>0</mn><mi 
>k</mi><mi 
>Ω</mi></math>;
                                                                                            
                                                                                            
           </dd><dt class="description">
      <span 
class="ecso-1200">the level of hardware certiﬁcate</span> </dt><dd 
class="description">
           : compliance with ISO-60601-2-26 [<a 
href="#XISO-60601-2-26:2012">International Electrotechnical Commission</a>] including
           the following devices <a 
href="#XTheraPrax">NeuroCare</a> (NeuroConn<span 
class="cmsy-10x-x-120">©</span>, Munich, Germany) and <a 
href="#XEemagine">Eemagine<span 
class="cmsy-10x-x-120">©</span></a> (ANT
           Neuro, Berlin, Germany) were preferable.</dd></dl>
      </li></ul>
<!--l. 116--><p class="noindent" >If at least one point was checked, the quality was set to 2, otherwise a score of 1 was given for this
criteria.
</p><!--l. 118--><p class="indent" >   We provided in the Github repository [<a 
href="#XBussalb2018">Bussalb</a>, <a 
href="#XBussalb2018">2018a</a>] the raw data extracted from the publications. To
prevent any bias in the analysis, the names of the factors were hidden during the entire analysis so that the
data scientist (AB) was fully blind to them. The variable names were only revealed once the data analysis
and results were accepted as valid: this included choice of variable normalization and validation of model
hypothesis as detailed below.
</p><!--l. 123--><p class="indent" >   The pre-processing of factors for the analysis included the following steps: factors for which there were
too many missing observations, arbitrarily set to more than 20% of the total of observations, were removed
from the analysis. Furthermore, if a factor had more than 80% similar observations it was removed as well.
Categorical variables were coded as dummies meaning that the presence of the factor was
represented with 1 and its absence 0. All variables were standardized by subtracting the mean
and then dividing this result by the standard deviation, except when the decision tree was
performed.
</p><!--l. 130--><p class="noindent" >
</p>
   <h5 class="subsubsectionHead"><span class="titlemark">2.4.2   </span> <a 
 id="x1-80002.4.2"></a>Explaining eﬀect sizes with factors</h5>
<!--l. 132--><p class="noindent" >To compute the <a 
href="#glo:es">ES</a>, the means of total <a 
href="#glo:adhd">ADHD</a> scores given by parents and teachers were used. Besides, in
case studies provided results for more than one behavioral scale, <a 
href="#glo:es">ES</a> were computed for each one
as
</p>
   <table class="equation-star"><tr><td>
                                                                                            
                                                                                            
<!--l. 135--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="block" class="equation">
                                  <mstyle 
class="text"><mtext  >ES</mtext></mstyle> <mo 
class="MathClass-rel">=</mo> <mfrac><mrow 
><msub><mrow 
><mi 
>M</mi></mrow><mrow 
><mstyle 
class="text"><mtext  >post</mtext></mstyle><mo 
class="MathClass-punc">,</mo><mi 
>T</mi> </mrow></msub 
> <mo 
class="MathClass-bin">−</mo> <msub><mrow 
><mi 
>M</mi></mrow><mrow 
><mstyle 
class="text"><mtext  >pre</mtext></mstyle><mo 
class="MathClass-punc">,</mo><mi 
>T</mi> </mrow></msub 
></mrow> 
<mrow 
><msqrt><mrow><mfrac><mrow 
><msubsup><mrow 
><mi 
>σ</mi></mrow><mrow 
><mstyle 
class="text"><mtext  >pre</mtext></mstyle> <mo 
class="MathClass-punc">,</mo><mi 
>T</mi> </mrow> <mrow 
>  <mn>2</mn> </mrow> </msubsup 
><mo 
class="MathClass-bin">+</mo><msubsup><mrow 
><mi 
>σ</mi></mrow><mrow 
><mstyle 
class="text"><mtext  >post</mtext></mstyle> <mo 
class="MathClass-punc">,</mo><mi 
>T</mi> </mrow> <mrow 
>  <mn>2</mn> </mrow> </msubsup 
></mrow>
               <mrow 
><mn>2</mn></mrow></mfrac></mrow></msqrt>             </mrow></mfrac> <mo 
class="MathClass-punc">,</mo>
</math></td></tr></table>
<!--l. 140--><p class="indent" >   where <!--l. 140--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msub><mrow 
><mi 
>M</mi></mrow><mrow 
><mi 
>t</mi><mo 
class="MathClass-punc">,</mo><mi 
>T</mi> </mrow></msub 
></math> is the mean of
clinical scale, for treatment <!--l. 140--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mi 
>T</mi></math>,
taken at time <!--l. 140--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mi 
>t</mi></math> (pre-test
or post-test) and <!--l. 140--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mi 
>σ</mi></math>
represents its standard deviation.
</p><!--l. 143--><p class="indent" >   The <a 
href="#glo:es">ES</a> computed in this analysis was diﬀerent from the one used for the replication and update of
<a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>]. Indeed, here we focused on the eﬀect of the treatment within a group as deﬁned
by <a 
href="#XCohen1988">Cohen</a> [<a 
href="#XCohen1988">1988</a>] using a deﬁnition of the <a 
href="#glo:es">ES</a> that was already used in the literature [<a 
href="#XArns2009">Arns
et al.</a>, <a 
href="#XArns2009">2009</a>; <a 
href="#XMaurizio2014">Maurizio et al.</a>, <a 
href="#XMaurizio2014">2014</a>; <a 
href="#XStrehl2017">Strehl et al.</a>, <a 
href="#XStrehl2017">2017</a>]. This <a 
href="#glo:es">ES</a> enables to quantify the eﬃcacy of <a 
href="#glo:nfb">NFB</a>
inside the treatment group.
</p><!--l. 148--><p class="indent" >   The <a 
href="#glo:es">ES</a> was then considered as a dependent variable to be explained by the factors (the independent
variables). The following three methods, implemented in the Scikit-Learn Python [<a 
href="#XPedregosa2011">Pedregosa et al.</a>, <a 
href="#XPedregosa2011">2011</a>,
0.18.1] and the Statsmodels Python [<a 
href="#XSeabold2010">Seabold and Perktold</a>, <a 
href="#XSeabold2010">2010</a>, 0.8.0] libraries, were used to perform the
regression: </p>
      <ul class="itemize1">
      <li class="itemize">weighted   multiple   linear   regression   (<a 
href="#glo:wls">Weighted   Least   Squares   (WLS)</a>)   [<a 
href="#XMontgomery2012">Montgomery
      et al.</a>, <a 
href="#XMontgomery2012">2012</a>];
      </li>
      <li class="itemize">sparsity-regularized linear regression with <a 
href="#glo:lasso">Least Absolute Shrinkage and Selection Operator
      (LASSO)</a> [<a 
href="#XTibshirani1996">Tibshirani</a>, <a 
href="#XTibshirani1996">1996</a>];
      </li>
      <li class="itemize">decision tree [<a 
href="#XQuinlan1986">Quinlan</a>, <a 
href="#XQuinlan1986">1986</a>].</li></ul>
<!--l. 157--><p class="indent" >   To illustrate simply our approach, the aim of the linear regression was ﬁrst to estimate the regression
coeﬃcients linking the factors to the <a 
href="#glo:es">ES</a>. A signiﬁcant coeﬃcient (meaning signiﬁcantly diﬀerent from 0)
indicated that the associated factor had probably an inﬂuence on <a 
href="#glo:nfb">NFB</a> eﬃcacy and the sign of the
coeﬃcient indicated the direction of the eﬀect.
</p><!--l. 162--><p class="indent" >   The <a 
href="#glo:wls">WLS</a> varies from a traditional linear regression estimated with <a 
href="#glo:ols">Ordinary Least Squares (OLS)</a> in the
                                                                                            
                                                                                            
sense that a weight was assigned to each observation so as to account for the multiplicity of reported
clinical endpoints in some studies. Besides, the weight was also a function of the sample size to
account for variations in sample sizes. Consequently, the weight of each study was taken as
the ratio between the experiment group’s sample size and the number of behavioral scales
available. We also ran the analysis with <a 
href="#glo:ols">OLS</a> method to assess the impact of the weights on the
results.
</p><!--l. 168--><p class="indent" >   The second linear method applied was the <a 
href="#glo:lasso">LASSO</a>, that naturally incorporates variable selection to the linear model
thanks to <!--l. 169--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mi 
>ℓ</mi> <mo 
class="MathClass-bin">−</mo> <mn>1</mn></math>-norm
applied on the coeﬃcients. A coeﬃcient not set at zero means that the associated factor may have had an
inﬂuence on <a 
href="#glo:nfb">NFB</a> and, once again, the sign of the coeﬃcient indicated the direction of the
eﬀect.
</p><!--l. 173--><p class="indent" >   The last method used to determine factors inﬂuencing <a 
href="#glo:nfb">NFB</a> was the decision tree [<a 
href="#XQuinlan1986">Quinlan</a>, <a 
href="#XQuinlan1986">1986</a>], a
hierarchical and non linear method. It braked down a dataset into smaller and smaller subsets using, at
each iteration, a variable and a threshold chosen to optimize a simple <a 
href="#glo:mse">Mean Square Error (MSE)</a> criteria
[<a 
href="#XJames2013">James et al.</a>, <a 
href="#XJames2013">2013</a>]. A tree is composed of several nodes and leafs, the importance of which is decreasing
from the top node called root node.
</p><!--l. 178--><p class="indent" >   These methods are intrinsically diﬀerent from each others, so we compared their results. For instance,
the decision tree captures variable interactions and can relate factors to <a 
href="#glo:es">ES</a> in a non-linear fashion. On the
other hand, the <a 
href="#glo:lasso">LASSO</a> oﬀers an elegant mathematical framework to variable selection. For more details,
please refer to the Supplemental Material [<a 
href="#XSupplementalmaterial">Bussalb</a>, <a 
href="#XSupplementalmaterial">2018b</a>].
</p><!--l. 7--><p class="noindent" >
</p>
   <h3 class="sectionHead"><span class="titlemark">3   </span> <a 
 id="x1-90003"></a>Results</h3>
<!--l. 9--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">3.1   </span> <a 
 id="x1-100003.1"></a>Studies selected</h4>
<!--l. 11--><p class="noindent" >Search terms entered in Pubmed returned 152 results during the last check on February 12, 2018 including
28 articles included in previous meta-analysis on <a 
href="#glo:nfb">NFB</a>. After the selection process illustrated in <a 
href="#x1-240011">1<!--tex4ht:ref: Figure:systematic_review_workflow --></a>, 31
studies were included in the <a 
href="#glo:saob">SAOB</a> and 15 in the meta-analysis as summarized in <a 
href="#x1-250011">1<!--tex4ht:ref: Table:table_factors_analysis_meta_analysis_list_studies --></a>. The 31 studies
                                                                                            
                                                                                            
selected for the <a 
href="#glo:saob">SAOB</a> followed the <a 
href="#XCortese2016">Cortese et al.</a>’s criteria to the exception of the requirement for a
control group. Indeed, since within <a 
href="#glo:es">ES</a> were considered in this analysis, a control group was not
required.
</p><!--l. 18--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">3.2   </span> <a 
 id="x1-110003.2"></a>Meta-analysis</h4>
<!--l. 20--><p class="noindent" >The validation of the Python module used for this work was successful (details available in Supplemental
Materials) and the code was made available online [<a 
href="#XBussalb2018">Bussalb</a>, <a 
href="#XBussalb2018">2018a</a>].
</p><!--l. 23--><p class="indent" >   The replication and the update of <a 
href="#XCortese2016">Cortese et al.</a>’s study was conducted by applying the
choices described in the Materials and Methods part and the results obtained are presented
in <a 
href="#x1-250022">2<!--tex4ht:ref: Table:meta_review_comparison_revman_and_python_with_choices --></a>:
</p>
      <ul class="itemize1">
      <li class="itemize">when computing the <a 
href="#glo:es">ES</a> for <a 
href="#XArnold2014">Arnold et al.</a> [<a 
href="#XArnold2014">2014</a>] with the values after 40 sessions of <a 
href="#glo:nfb">NFB</a>,
      smaller <a 
href="#glo:es">ES</a> were found than <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>], which is someone counter intuitive as one
      expect the clinical eﬃcacy to increase with the number of <a 
href="#glo:nfb">NFB</a> session;
      </li>
      <li class="itemize">when relying on the teachers’ ratings from the Conners-3 to compute the <a 
href="#glo:es">ES</a> of <a 
href="#XSteiner2014">Steiner
      et al.</a> [<a 
href="#XSteiner2014">2014</a>],  higher  <a 
href="#glo:se">Summary  Eﬀect  (SE)</a>  were  found  in  attention  but  not  in  total  and
      hyperactivity. However, this diﬀerent choice of scale did not aﬀect the signiﬁcance of the <a 
href="#glo:se">SEs</a>.</li></ul>
<!--l. 36--><p class="indent" >   The meta-analysis was then extended by adding two new articles [<a 
href="#XStrehl2017">Strehl et al.</a>, <a 
href="#XStrehl2017">2017</a>; <a 
href="#XBaumeister2016">Baumeister
et al.</a>, <a 
href="#XBaumeister2016">2016</a>] found by applying the same search criteria and ﬁnding more recent matches.
<a 
href="#XBaumeister2016">Baumeister et al.</a> [<a 
href="#XBaumeister2016">2016</a>] provided results only for parents total outcome whereas <a 
href="#XStrehl2017">Strehl et al.</a> [<a 
href="#XStrehl2017">2017</a>]
gave teachers and parents’ assessments for all outcomes. Despite favorable results for <a 
href="#glo:nfb">NFB</a>,
particularly on parents’ assessments, adding these two new studies did not change neither the
magnitude nor the signiﬁcance of the <a 
href="#glo:se">SE</a> for any outcome whatever the raters as illustrated
in <a 
href="#x1-240022">2<!--tex4ht:ref: Figure:meta_review_forest_plots_update_meta_analysis_our_choices_no_colors_2-columns_fitting_image --></a>.
</p><!--l. 43--><p class="indent" >   As initially suggested by <a 
href="#XCortese2016">Cortese et al.</a>, the analysis was ran on two subgroups of studies: one gathering
studies following the standard protocol deﬁned by <a 
href="#XArns2014">Arns et al.</a> [<a 
href="#XArns2014">2014</a>] and a second only including
participants without drug during the clinical trial.
                                                                                            
                                                                                            
</p><!--l. 47--><p class="indent" >   Regarding the ‘standard protocol’ subgroup, <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>] found all the outcomes
signiﬁcant except for the hyperactivity symptoms rated by teachers, which only showed a statistical
trend (p-value = 0.11). Similar results was obtained when adding the most recent studies
meeting this deﬁnition [<a 
href="#XStrehl2017">Strehl et al.</a>, <a 
href="#XStrehl2017">2017</a>] (p-value = 0.11). The <a 
href="#glo:se">SE</a> for the total outcome
assessed by teachers remained signiﬁcant with the addition of the two new <a 
href="#glo:rct">RCTs</a> (p-value =
0.043) giving more weight to this result given that it now is based on 4 studies including 283
patients.
</p><!--l. 54--><p class="indent" >   As for the no-drug subgroup, <a 
href="#glo:se">SEs</a> were found signiﬁcant for the inattention symptoms assessed by
parents (p-value = 0.013). Besides, the diﬀerences in <a 
href="#XArnold2014">Arnold et al.</a> [<a 
href="#XArnold2014">2014</a>] values caused a loss of
signiﬁcance in hyperactivity outcome for parents (p-value = 0.066) compared to <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>]
(p-value = 0.016). The two new studies were not included in this subgroup because subjects were taking
psychostimulants during the trial.
</p><!--l. 59--><p class="indent" >   All the clinical scales used to compute the <a 
href="#glo:es">ES</a> following our choices are summarized in the Supplemental
Materials.
</p><!--l. 61--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">3.3   </span> <a 
 id="x1-120003.3"></a>Factors inﬂuencing Neurofeedback</h4>
<!--l. 63--><p class="noindent" >This analysis was performed on 31 trials assessing the eﬃcacy of <a 
href="#glo:nfb">NFB</a> as presented in <a 
href="#x1-250011">1<!--tex4ht:ref: Table:table_factors_analysis_meta_analysis_list_studies --></a>. Among the 25
factors selected, 6 were removed for missing too many observations or being too homogeneous: beta up in
frontal areas, the use of a transfer card, the type of threshold for the rewards (incremental or ﬁxed), the
EEG quality equal of 3 (meaning that the electrodes used were either <a 
href="#glo:agcl">AgCl</a>/Gel or <a 
href="#glo:au">Au</a>/Gel, a check of
electrode contact quality was performed, and the hardware used was CE marked), and the presence of a
control group.
</p><!--l. 70--><p class="indent" >   The <a 
href="#glo:es">ES</a> within subjects was computed for all available clinical scales of each study and then factors
were associated with the computed <a 
href="#glo:es">ES</a> using three diﬀerent methods: the <a 
href="#glo:wls">WLS</a>, the <a 
href="#glo:lasso">LASSO</a>, and the
decision tree. The global results were presented in <a 
href="#x1-250033">3<!--tex4ht:ref: Table:table_factors_analysis_results_summary --></a>. These results highlight require a careful interpretation
since each technique provides with slightly diﬀerent results. Understandably, these diﬀerences steered from
the variations in hypothesis of each model. Yet, the more methods identiﬁed a factor, the
more conﬁdent one could be in its contribution to explain the <a 
href="#glo:es">ES</a> under diﬀerent modeling
hypothesis.
</p><!--l. 77--><p class="indent" >   The <a 
href="#glo:wls">WLS</a> technique identiﬁed 8 factors signiﬁcantly diﬀerent from zero for an adjusted R-squared of
0.74 which is rather satisfying. When applying the <a 
href="#glo:ols">OLS</a>, the same factors were signiﬁcant except the
                                                                                            
                                                                                            
presence of a transfer phase, the protocol theta down, and the artifact correction based on amplitude
with an lower adjusted R-squared (0.42). The <a 
href="#glo:lasso">LASSO</a> regression selected signiﬁcant factors by
setting to 0 the factors that did not explain the model, here 12 factors contributed to the
model. With these two methods, a negative coeﬃcient meant that the factor was in favor of the
<a 
href="#glo:nfb">NFB</a>.
</p><!--l. 84--><p class="indent" >   Eventually, the decision tree presented in <a 
href="#x1-240033">3<!--tex4ht:ref: Figure:factors_analysis_decision_tree_results --></a> split the dataset with a threshold value on the
factor representing each node. From top to bottom, each factor is chosen to provide with a
split minimizing an <a 
href="#glo:mse">MSE</a> function. The best predictor is naturally the one at the top of the
tree: in our case it was the <a 
href="#glo:pblind">PBLIND</a>. Five other factors also split the subsets, however, the
lower we got into the tree, the less samples were available, making interpretation harder and
harder.
</p><!--l. 90--><p class="indent" >   Several factors were common to the three methods used, in particular the treatment length, the
assessment by a blind rater, and <a 
href="#glo:eeg">EEG</a> quality of 2 (meaning that either the type of electrode used, the
check of the electrode contacts, or the use of CE marked hardware was satisﬁed) that were all three
returned by the three methods. Besides, the methods agreed on the direction of the inﬂuence of these
factors. So, a shorter treatment and recording the <a 
href="#glo:eeg">EEG</a> with a good system seemed preferable, whereas
teachers’ assessment appeared less favorable.
</p><!--l. 96--><p class="indent" >   It was more diﬃcult to interpret the inﬂuence of the factors returned by only one or two methods.
Indeed, it was not clear if they were selected due to an imprecision of the method or if they really had an
impact on <a 
href="#glo:nfb">NFB</a> eﬃcacy. For instance, both <a 
href="#glo:wls">WLS</a> and <a 
href="#glo:lasso">LASSO</a> found that relying on the amplitude of the
signal to correct artifacts, and including a transfer phase seemed not to improve <a 
href="#glo:adhd">ADHD</a> symptoms.
Conversely, the <a 
href="#glo:irb">IRB</a> approval, a theta down protocol, and a high number of sessions per week appeared to
positively inﬂuence the results. The decision tree and <a 
href="#glo:lasso">LASSO</a> had in common the protocol <a 
href="#glo:smr">SMR</a>: it was
associated with lower <a 
href="#glo:es">ES</a>. Five factors were returned by only one of the methods: the minimal age of
the children, being on drugs during <a 
href="#glo:nfb">NFB</a> treatment, randomizing the groups and the <a 
href="#glo:scp">SCPs</a>
protocol.
</p><!--l. 104--><p class="indent" >   Eventually, ﬁve factors were selected by no method: the correction for the ocular artifact, the children
maximum age, the number of sessions, the protocol beta up in central areas and the presence of
more than one active electrode. Thus, these factors appeared not to have an inﬂuence on <a 
href="#glo:nfb">NFB</a>
eﬃcacy.
</p><!--l. 108--><p class="indent" >   To avoid over interpreting results we only discuss below the factors that were selected by at least 2 of
three methods.
                                                                                            
                                                                                            
</p><!--l. 7--><p class="noindent" >
</p>
   <h3 class="sectionHead"><span class="titlemark">4   </span> <a 
 id="x1-130004"></a>Discussion</h3>
<!--l. 9--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">4.1   </span> <a 
 id="x1-140004.1"></a>Perform the meta-analysis</h4>
<!--l. 11--><p class="noindent" >In the meta-analysis performed here, we challenged some choices made by <a 
href="#XCortese2016">Cortese et al.</a>, which proved
controversial: the computation of <a 
href="#glo:es">ES</a> based on an unusual scale [<a 
href="#XSteiner2014">Steiner et al.</a>, <a 
href="#XSteiner2014">2014</a>] and the inclusion of a
pilot study [<a 
href="#XArnold2014">Arnold et al.</a>, <a 
href="#XArnold2014">2014</a>] whose end point values were not available at the time <a 
href="#XCortese2016">Cortese et al.</a>
conducted his meta-analysis. We review here the list of changes, their justiﬁcation, and their impact on the
analysis.
</p><!--l. 16--><p class="indent" >   First, relying on the Conners-3 [<a 
href="#XConners2008">Conners</a>, <a 
href="#XConners2008">2008</a>] instead of the BOSS Classroom Observation
[<a 
href="#XShapiro2010">Shapiro</a>, <a 
href="#XShapiro2010">2010</a>] for teachers ratings seemed preferable because this scale is more commonly used
[<a 
href="#XChristiansen2014">Christiansen et al.</a>, <a 
href="#XChristiansen2014">2014</a>; <a 
href="#XBluschke2016">Bluschke et al.</a>, <a 
href="#XBluschke2016">2016</a>] and is the revision of the Conners Rating Scale Revised
[<a 
href="#XConners1998">Conners et al.</a>, <a 
href="#XConners1998">1998</a>] whose reliability has been studied [<a 
href="#XCollett2003">Collett et al.</a>, <a 
href="#XCollett2003">2003</a>]. However, relying
on one or the other scale did not change the signiﬁcance of the <a 
href="#glo:es">ES</a> whatever the outcome
studied.
</p><!--l. 21--><p class="indent" >   Second, to compute the <a 
href="#glo:es">ES</a> of <a 
href="#XArnold2014">Arnold et al.</a> [<a 
href="#XArnold2014">2014</a>] the clinical scores taken when all sessions were
completed were used instead of looking at interim results as in <a 
href="#XCortese2016">Cortese et al.</a>. Some studies suggested that
the number of sessions correlates positively with the changes observed in the <a 
href="#glo:eeg">EEG</a> [<a 
href="#XVernon2004">Vernon
et al.</a>, <a 
href="#XVernon2004">2004</a>] so that a lower number of sessions would lead to artiﬁcially smaller <a 
href="#glo:es">ES</a>. Here, the
<a 
href="#glo:es">ES</a> computed with the values at post test of <a 
href="#XArnold2014">Arnold et al.</a> [<a 
href="#XArnold2014">2014</a>] were smaller than those
obtained after 12 sessions but these diﬀerences did not lead to a change of signiﬁcance of the
<a 
href="#glo:se">SE</a>.
</p><!--l. 27--><p class="indent" >   To conclude on that meta-analysis, though some points from the original were controversial and the
fact that - for the reasons mentioned earlier - diﬀerent choices could reasonably be made, it turned out
that the impact on the meta-analysis results were minimal and did not change the statistical signiﬁcance of
any outcome. Consequently, the completion of the meta-analysis with studies published since the
publication of his work were done with the choices: </p>
      <ul class="itemize1">
      <li class="itemize">to compute the <a 
href="#glo:es">ES</a> of <a 
href="#XArnold2014">Arnold et al.</a> [<a 
href="#XArnold2014">2014</a>] the end point values were used;
                                                                                            
                                                                                            
      </li>
      <li class="itemize">the scores reported by teachers on the Conners-3 in <a 
href="#XSteiner2014">Steiner et al.</a>’s study were taken into
      account instead of these of the BOSS Classroom Observation.</li></ul>
<!--l. 37--><p class="indent" >   The addition of the two new studies [<a 
href="#XStrehl2017">Strehl et al.</a>, <a 
href="#XStrehl2017">2017</a>; <a 
href="#XBaumeister2016">Baumeister et al.</a>, <a 
href="#XBaumeister2016">2016</a>] further
conﬁrmed original results. Indeed, the signiﬁcance did not change for any outcome: <a 
href="#glo:se">SE</a> found
remained signiﬁcant for <a 
href="#glo:mprox">MPROX</a> raters and non-signiﬁcant for <a 
href="#glo:pblind">PBLIND</a>. Adding two more studies
increased the signiﬁcance of the sensitivity analysis ran by <a 
href="#XCortese2016">Cortese et al.</a>, most notably, the <a 
href="#glo:se">SE</a> of
studies corresponding to <a 
href="#glo:nfb">NFB</a> standard protocols <a 
href="#XArns2014">Arns et al.</a> [<a 
href="#XArns2014">2014</a>]. While <a 
href="#XCortese2016">Cortese et al.</a> found
that this subset tended to perform better, particularly on the <a 
href="#glo:pblind">PBLIND</a> outcome, adding two
studies conﬁrmed this result on the total clinical score (p-value &#x003C; 0.05). Despite the obvious
heterogeneity of the studies included in this subset (particularly in terms of protocol used),
this result suggests a positive relation between the features of this <span 
class="ecsi-1200">standard </span>design and <a 
href="#glo:nfb">NFB</a>
performance.
</p><!--l. 46--><p class="indent" >   This replication and update of a meta-analysis did not meet all PRISMA recommendations. In
particular, the risk of bias in individual and across studies was not assessed.
</p><!--l. 49--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">4.2   </span> <a 
 id="x1-150004.2"></a>Factors inﬂuencing Neurofeedback</h4>
<!--l. 51--><p class="noindent" >Description and analysis of diﬀerent types of <a 
href="#glo:nfb">NFB</a> implementation was subject to several studies [<a 
href="#XArns2014">Arns
et al.</a>, <a 
href="#XArns2014">2014</a>; <a 
href="#XEnriquez2017">Enriquez-Geppert et al.</a>, <a 
href="#XEnriquez2017">2017</a>; <a 
href="#XVernon2004">Vernon et al.</a>, <a 
href="#XVernon2004">2004</a>; <a 
href="#XJeunet2018">Jeunet et al.</a>, <a 
href="#XJeunet2018">2018</a>] but to our
knowledge none used statistical tools to quantify their inﬂuence on clinical endpoints.
</p><!--l. 55--><p class="indent" >   The interpretation of results provided by this analysis requires some care granted that each method
oﬀer slightly diﬀerent results. These discrepancies can easily be explained by the varying hypothesis of each
model and actually oﬀered interesting insight into the results and their signiﬁcance. For instance, the
decision tree method is a non-linear method that accounts for variables interaction unlike the other
two.
</p><!--l. 60--><p class="indent" >   Surprisingly, the number of sessions was not found as a signiﬁcant factor by any method, which was
somewhat in contradiction with existing literature. For instance, <a 
href="#XEnriquez2017">Enriquez-Geppert et al.</a> [<a 
href="#XEnriquez2017">2017</a>] insisted on
the fact that the number of sessions should be chosen carefully to avoid &#x0022;overtraining&#x0022;. Moreover, <a 
href="#XArns2014">Arns
et al.</a> [<a 
href="#XArns2014">2014</a>] stated that performing less than 20 <a 
href="#glo:nfb">NFB</a> sessions led to smaller eﬀects. Similarly, <a 
href="#XVernon2004">Vernon
et al.</a> [<a 
href="#XVernon2004">2004</a>] observed that positive changes in the <a 
href="#glo:eeg">EEG</a> and behavioral performance occurred after a
                                                                                            
                                                                                            
minimum of 20 sessions.
</p><!--l. 66--><p class="indent" >   The fact that the number of sessions was not identiﬁed as a positively contributing factor, might be
explain by the presence of only one data point with 20 sessions or less. Possibly, the temporal threshold of
eﬃcacy was passed for all included studies making the identiﬁcation of this factor unlikely on this dataset.
However, regardless of its statistical signiﬁcance, the coeﬃcient found by the <a 
href="#glo:wls">WLS</a> was negative,
meaning that as expected, the more sessions performed the more eﬃcient the <a 
href="#glo:nfb">NFB</a> seemed to
be.
</p><!--l. 72--><p class="indent" >   Interestingly, [<a 
href="#XMinder2018">Minder et al.</a>, <a 
href="#XMinder2018">2018</a>] suggests that the location of the <a 
href="#glo:nfb">NFB</a> training may also be an
important contributing factor to clinical eﬀectiveness. This was however recently investigated by a recent
study [<a 
href="#XMinder2018">Minder et al.</a>, <a 
href="#XMinder2018">2018</a>] showing that performing <a 
href="#glo:nfb">NFB</a> at school or at the clinic has no signiﬁcant
impact on treatment response.
</p><!--l. 76--><p class="indent" >   The type of <a 
href="#glo:nfb">NFB</a> protocol was not identiﬁed by all the three methods but it seemed to inﬂuence the
<a 
href="#glo:nfb">NFB</a> results according to 2 methods. In particular, the theta down protocol appeared more
eﬃcient and the <a 
href="#glo:smr">SMR</a> protocol associated with lower <a 
href="#glo:es">ES</a>. This importance granted by the
methods to the <a 
href="#glo:nfb">NFB</a> protocols was somewhat lower to expectations given their centrality in the
neurophysiological mode of action and subsequent expected impact on therapeutic eﬀectiveness <a 
href="#XVernon2004">Vernon
et al.</a> [<a 
href="#XVernon2004">2004</a>]. A possible explanation for this result is that these protocols were equally eﬃcacious to
the populations they were oﬀered to and thereby did not constitute a signiﬁcant explanatory
factor. This result, however, does not preclude a combined and personalized strategy (oﬀer
the right protocol to the right kid) to further improve performance as previously by <a 
href="#XAlkoby2017">Alkoby
et al.</a> [<a 
href="#XAlkoby2017">2017</a>].
</p><!--l. 85--><p class="indent" >   Several factors were selected by all three methods with the same direction of inﬂuence: the EEG quality,
the treatment length, and if the rater was probably blind to the treatment.
</p><!--l. 88--><p class="indent" >   First, this analysis pointed out the fact that recording <a 
href="#glo:eeg">EEG</a> in good conditions seemed to lead to better
results, which could be explained by the fact that better signal quality enabled to extract more correctly the
<a 
href="#glo:eeg">EEG</a> patterns linked to <a 
href="#glo:adhd">ADHD</a> and henceforth led to better learning and therapeutic eﬃcacy. However, it
remained diﬃcult to really assess the quality of the hardware because little information was provided in the
studies.
</p><!--l. 93--><p class="indent" >   Next, it appeared here that the longer the treatment, the less eﬃcient it became. Arguably, the
treatment length was a proxy for treatment intensity, which meant that a treatment that was short in
length (and consequently intense in pace) was more likely to succeed. This hypothesis was back-up by the
fact that the variable <span 
class="ecsi-1200">session pace </span>(number of sessions per week) was also associated with larger <a 
href="#glo:es">ES</a>
according to the <a 
href="#glo:wls">WLS</a> and <a 
href="#glo:lasso">LASSO</a>. Impact of the intensity of treatment have been investigated by [<a 
href="#XRogala2016">Rogala
et al.</a>, <a 
href="#XRogala2016">2016</a>] on healthy adults: it was observed that studies with at least four training sessions completed
                                                                                            
                                                                                            
on consecutive days were all successful.
</p><!--l. 100--><p class="indent" >   As expected, the assessment of symptoms by non-blind raters led to far more favorable results than by
<a 
href="#glo:pblind">PBLIND</a> raters - result widely expected and in close compliance with existing meta-analysis [<a 
href="#XCortese2016">Cortese
et al.</a>, <a 
href="#XCortese2016">2016</a>; <a 
href="#XMicoulaud2014">Micoulaud-Franchi et al.</a>, <a 
href="#XMicoulaud2014">2014</a>]. This last point was investigated more precisely to determine
if this observation could be solely explained by the placebo eﬀect.
</p><!--l. 104--><p class="noindent" >
</p>
   <h4 class="subsectionHead"><span class="titlemark">4.3   </span> <a 
 id="x1-160004.3"></a>Analysis on the probably blind raters</h4>
<!--l. 106--><p class="noindent" >Teachers were considered as <a 
href="#glo:pblind">PBLIND</a> raters as <a 
href="#XCortese2016">Cortese et al.</a>; <a 
href="#XMicoulaud2014">Micoulaud-Franchi et al.</a> did. The stress put
on <span 
class="ecsi-1200">probably </span>indicated that teachers may nonetheless be aware of the treatment followed. An element that
corroborates this hypothesis is the fact that on all the studies included in this work, the amplitude of the
clinical scale at baseline suggests that teachers did not capture the full extend of the symptoms or, say it
diﬀerently, that they were more blind to the symptoms than to the intervention as illustrated in <a 
href="#x1-240044">4<!--tex4ht:ref: Figure:discussion_on_placebo_effect_colors_2-columns_fitting_image --></a>. The
expected diﬀerences of ratings between teachers and parents have been extensively studied [<a 
href="#XSollie2013">Sollie
et al.</a>, <a 
href="#XSollie2013">2013</a>; <a 
href="#XNarad2015">Narad et al.</a>, <a 
href="#XNarad2015">2015</a>; <a 
href="#XMinder2018">Minder et al.</a>, <a 
href="#XMinder2018">2018</a>] noting that teachers were more likely to underrate a
child’s severity, and especially so for younger children. As a consequence, teachers might just
very well be less likely to observe a clinical change over the course of the treatment (prone
to type II error) [<a 
href="#XSollie2013">Sollie et al.</a>, <a 
href="#XSollie2013">2013</a>; <a 
href="#XNarad2015">Narad et al.</a>, <a 
href="#XNarad2015">2015</a>; <a 
href="#XMinder2018">Minder et al.</a>, <a 
href="#XMinder2018">2018</a>]. Besides, it is
also clear that there is more variability in teachers’ scores compared to parents’, which could
partly explained the lower <a 
href="#glo:es">ES</a> obtained for <a 
href="#glo:pblind">PBLIND</a> raters since the variability will inﬂuence the
denominator. So using <a 
href="#glo:pblind">PBLIND</a> as an estimate for correcting the placebo eﬀect might not be
optimal.
</p><!--l. 119--><p class="indent" >   Strangely, the data provided did not exactly matched the widely accepted hypothesis stating that the
diﬀerence between <a 
href="#glo:mprox">MPROX</a> and <a 
href="#glo:pblind">PBLIND</a> can solely be explained by the placebo eﬀect.
</p><!--l. 122--><p class="indent" >   Another way to highlight a possible placebo eﬀect, was to focus on the decision tree illustrated by
Figure <a 
href="#x1-240033">3<!--tex4ht:ref: Figure:factors_analysis_decision_tree_results --></a>, whose results provide a good insight to comment on this. Indeed, the top node splits on one hand
43 observations corresponding to <a 
href="#glo:mprox">MPROX</a> raters and, on the other hand, 19 observations corresponding to
<a 
href="#glo:pblind">PBLIND</a>. If the diﬀerences observed between <a 
href="#glo:pblind">PBLIND</a> and <a 
href="#glo:mprox">MPROX</a> raters were due to the placebo eﬀect,
one would expect to ﬁnd in the <a 
href="#glo:mprox">MPROX</a> part of the decision tree factors linked to the perception of or
implication into the treatment. It was, indeed the case: session and treatment length were found but
with an opposite contribution than expected if they were contributing to a placebo eﬀect.
Indeed, one would expect that the longer the session and the treatment, the higher the placebo
                                                                                            
                                                                                            
eﬀect and the larger the within-<a 
href="#glo:es">ES</a>. Yet, the opposite was found, somewhat invalidating the
hypothesis.
</p><!--l. 132--><p class="indent" >   These results altogether suggest that <a 
href="#glo:pblind">PBLIND</a> assessments could hardly be used to assess placebo
eﬀect as they seemed to be blinder to symptoms than to intervention. In the absence of ethically
[<a 
href="#XHoltmann2014">Holtmann et al.</a>, <a 
href="#XHoltmann2014">2014</a>] and technically [<a 
href="#XBirbaumer1991">Birbaumer</a>, <a 
href="#XBirbaumer1991">1991</a>] feasible sham for <a 
href="#glo:nfb">NFB</a> protocols [<a 
href="#XWorld-Medical-Association2000">World Medical
Association</a>, <a 
href="#XWorld-Medical-Association2000">2000</a>], it is necessary to fallback on acceptable methodological alternative to the
demonstration of clinical eﬀectiveness. Among those are analysis of neuromarkers collected during
<a 
href="#glo:nfb">NFB</a> treatment demonstrating that patients do <span 
class="ecsi-1200">control </span>the trained neuromarkers; that they <span 
class="ecsi-1200">learn </span>(reinforce
control over time), and that these possibly lead to lasting brain reorganization (e.g. changes
in their baseline resting state activity). The speciﬁty of these changes, in relation to, which
neuromarkers were trained and clinical improvement will be an essential component of this
demonstration.
</p><!--l. 140--><p class="indent" >   It would have been interesting to study the inﬂuence of some other factors such as the delay between
brain state and feedback signal as well as the type of <a 
href="#glo:nfb">NFB</a> metaphor and feedback used as pointed out by
<a 
href="#XAlkoby2017">Alkoby et al.</a> [<a 
href="#XAlkoby2017">2017</a>], but these information were rarely available in studies. Besides, to add more reliability
to these results it should be preferable to add more studies, particularly studies with teachers assessments
(considered as <a 
href="#glo:pblind">PBLIND</a>).
</p><!--l. 6--><p class="noindent" >
</p>
   <h3 class="sectionHead"><span class="titlemark">5   </span> <a 
 id="x1-170005"></a>Conclusion</h3>
<!--l. 8--><p class="noindent" >This work conﬁrms <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>]’s ﬁndings in the light of recent published clinical work. In
particular, studies following a standard protocol as deﬁned by <a 
href="#XArns2014">Arns et al.</a> [<a 
href="#XArns2014">2014</a>] show signiﬁcant clinical
improvements on <a 
href="#glo:pblind">PBLIND</a> raters (k = 4 studies instead of 3 <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>]).
</p><!--l. 12--><p class="indent" >   Besides this meta-analysis, a new method is suggested to tackle the high heterogeneity of clinical data
available on <a 
href="#glo:nfb">NFB</a>. This method aims at identifying factors as positively or negatively contributing to <a 
href="#glo:nfb">NFB</a>
eﬃcacy. Three factors were consistently found to statistically signiﬁcantly explain clinical within-<a 
href="#glo:es">ES</a>. First,
the quality of acquisition of the <a 
href="#glo:eeg">EEG</a> was positively correlated with clinical eﬃcacy. It conﬁrms a mode of
action through speciﬁc <a 
href="#glo:eeg">EEG</a> training. Likewise, treatment intensity was found to contribute, corroborating
what is known of learning theory (memory consolidation) [<a 
href="#XMowrer1960">Mowrer</a>, <a 
href="#XMowrer1960">1960</a>], that is a more intense treatment
leads to an increased clinical eﬃcacy. Finally, results show that the therapeutic eﬃcacy measured by
teachers is reduced compared to that measured by parents. This result has long been documented
                                                                                            
                                                                                            
and it is widely accepted that this diﬀerence is solely imputable to the amplitude of placebo
eﬀect in <a 
href="#glo:nfb">NFB</a>. However, the data presented in this article tend to refute this hypothesis and
suggest that teachers are simply exposed to less symptoms, in line with the most recent work
on the topic. As a consequence, using <a 
href="#glo:pblind">PBLIND</a> endpoints to address the speciﬁcity of the
clinical eﬃcacy is not recommended and the community should instead rely on other available
methodological tools. Those include sham <a 
href="#glo:nfb">NFB</a> and neuromarker analysis investigating the
speciﬁcity of the <a 
href="#glo:eeg">EEG</a> changes with respect to trained neuromarkers and changes in clinical
endpoints.
</p><!--l. 27--><p class="indent" >   These elements converge to the conclusion that existing methodologies traditionally used to
assess drug treatments in neuropsychiatric conditions may not be fully ﬁt to the evaluation
of medical devices. The series of results presented here however suggest the presence of a
genuine signal in favor of the therapeutic eﬃcacy of <a 
href="#glo:nfb">NFB</a>. A signal that should nonetheless be
strengthen using the aforementioned methodological tools, neuromarker analysis in the ﬁrst
place.
</p><!--l. 32--><p class="indent" >   This work also oﬀers an open source tool for running meta-analysis and <a 
href="#glo:saob">SAOB</a>: the code and data used
are available, assuring the transparency and replicability of these analysis.
</p><!--l. 3--><p class="noindent" >
</p>
   <h3 class="likesectionHead"><a 
 id="x1-180005"></a>Conﬂict of Interest Statement</h3>
<!--l. 4--><p class="noindent" >A. Bussalb, Q. Barthelemy, D. Ojeda, and L. Mayaud work for Mensia Technologies. M. Congedo served as
an advisor for Mensia Technologies when this work was conducted.
</p><!--l. 7--><p class="noindent" >
</p>
   <h3 class="likesectionHead"><a 
 id="x1-190005"></a>Author Contributions</h3>
<!--l. 8--><p class="noindent" >AB extracted all data from articles and performed the analysis, MC provided useful advice concerning
statistics and the methods used, RD and EA followed closely the evolution of the work and provided
good ideas especially on the clinical level. QB and DO gave useful ideas to optimally apply
methods used in the <a 
href="#glo:saob">SAOB</a> and helped in the interpretation of the results. LM oversaw all this
work.
                                                                                            
                                                                                            
</p><!--l. 14--><p class="noindent" >
</p>
   <h3 class="likesectionHead"><a 
 id="x1-200005"></a>Funding</h3>
<!--l. 15--><p class="noindent" >This research was conducted as part of a PhD thesis funded by Mensia Technologies, the Association
Nationale Recherche et Technologie (ANRT), and the EU H2020 NEWROFEED grant.
</p><!--l. 3--><p class="noindent" >
</p>
   <h3 class="likesectionHead"><a 
 id="x1-210005"></a>Acknowledgments</h3>
<!--l. 5--><p class="noindent" >We would like to thank Jean-Arthur Micoulaud-Franchi, MD, PhD for his helpful comments and ideas on
that work. We also would to thank the Association Nationale Recherche et Technologie (ANRT) that
partly funded this thesis as well as the EU H2020 NEWROFEED grant.
</p><!--l. 1--><p class="indent" >   <a 
 id="likesection.1"></a>
</p>
   <h3 class="likesectionHead"><a 
 id="x1-220005"></a>List of abbreviations</h3>
<!--l. 2--><p class="noindent" >
      </p><dl class="description"><dt class="description">
<a 
 id="glo:adhd"></a><span 
class="ecsx-1200">ADHD</span> </dt><dd 
class="description">Attention Deﬁcit/Hyperactivity Disorder. 2–7, 9, 12, 15
      </dd><dt class="description">
<a 
 id="glo:agcl"></a><span 
class="ecsx-1200">AgCl</span> </dt><dd 
class="description">Silver Chloride. 8, 12
      </dd><dt class="description">
<a 
 id="glo:au"></a><span 
class="ecsx-1200">Au</span> </dt><dd 
class="description">Gold. 8, 12<p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:cpt"></a><span 
class="ecsx-1200">CPT</span> </dt><dd 
class="description">Continuous Performance Test. 3</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:eeg"></a><span 
class="ecsx-1200">EEG</span> </dt><dd 
class="description">Electroencephalogram. 3, 5, 8, 12, 13, 15, 17, 38
                                                                                            
                                                                                            
      </dd><dt class="description">
<a 
 id="glo:eog"></a><span 
class="ecsx-1200">EOG</span> </dt><dd 
class="description">Electro-Oculogram. 38
      </dd><dt class="description">
<a 
 id="glo:erp"></a><span 
class="ecsx-1200">ERP</span> </dt><dd 
class="description">Event-Related Potential. 4
      </dd><dt class="description">
<a 
 id="glo:es"></a><span 
class="ecsx-1200">ES</span> </dt><dd 
class="description">Eﬀect Size. 5–7, 9–17, 32, 33</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:fmri"></a><span 
class="ecsx-1200">fMRI</span> </dt><dd 
class="description">functional Magnetic Resonance Imaging. 3</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:irb"></a><span 
class="ecsx-1200">IRB</span> </dt><dd 
class="description">Institutional Review Board. 8, 12, 38</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:lasso"></a><span 
class="ecsx-1200">LASSO</span> </dt><dd 
class="description">Least Absolute Shrinkage and Selection Operator. 9, 10, 12, 13, 15, 38</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:mprox"></a><span 
class="ecsx-1200">MPROX</span> </dt><dd 
class="description">Most Proximal. 6, 14, 16, 34
      </dd><dt class="description">
<a 
 id="glo:mse"></a><span 
class="ecsx-1200">MSE</span> </dt><dd 
class="description">Mean Square Error. 10, 12, 33</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:nfb"></a><span 
class="ecsx-1200">NFB</span> </dt><dd 
class="description">Neurofeedback. 3–15, 17, 18, 31, 32, 36–38</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:ols"></a><span 
class="ecsx-1200">OLS</span> </dt><dd 
class="description">Ordinary Least Squares. 9, 10, 12</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:pblind"></a><span 
class="ecsx-1200">PBLIND</span> </dt><dd 
class="description">Probably Blind. 6, 12, 14, 16, 17, 34, 38
      </dd><dt class="description">
<a 
 id="glo:pet"></a><span 
class="ecsx-1200">PET</span> </dt><dd 
class="description">Positron Emission Tomography. 3</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:rct"></a><span 
class="ecsx-1200">RCT</span> </dt><dd 
class="description">Randomized Controlled Trial. 4, 11</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:saob"></a><span 
class="ecsx-1200">SAOB</span> </dt><dd 
class="description">Systematic Analysis of Biases. 5, 7, 10, 18, 36
                                                                                            
                                                                                            
      </dd><dt class="description">
<a 
 id="glo:sart"></a><span 
class="ecsx-1200">SART</span> </dt><dd 
class="description">Sustained Attention to Response Task. 3
      </dd><dt class="description">
<a 
 id="glo:scp"></a><span 
class="ecsx-1200">SCP</span> </dt><dd 
class="description">Slow Cortical Potential. 4, 8, 13, 38
      </dd><dt class="description">
<a 
 id="glo:se"></a><span 
class="ecsx-1200">SE</span> </dt><dd 
class="description">Summary Eﬀect. 11, 13, 14, 32, 37
      </dd><dt class="description">
<a 
 id="glo:smr"></a><span 
class="ecsx-1200">SMR</span> </dt><dd 
class="description">Sensorimotor Rhythm. 3, 4, 8, 13, 15, 38</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:tbr"></a><span 
class="ecsx-1200">TBR</span> </dt><dd 
class="description">Theta Beta Ratio. 4
      </dd><dt class="description">
<a 
 id="glo:tova"></a><span 
class="ecsx-1200">TOVA</span> </dt><dd 
class="description">Test of Variables of Attention. 3</p><p class="theindex">
      </dd><dt class="description">
<a 
 id="glo:wls"></a><span 
class="ecsx-1200">WLS</span> </dt><dd 
class="description">Weighted Least Squares. 9, 12, 15, 38</dd></dl>
                                                                                            
                                                                                            
   <h3 class="likesectionHead"><a 
 id="x1-230005"></a>References</h3>
<!--l. 1--><p class="noindent" >
  </p><div class="thebibliography">
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XAlkoby2017"></a><span class="bibsp">   </span></span>O. Alkoby, A. Abu-Rmileh, O. Shriki, and D. Todder.   Can we predict who will respond to
  neurofeedback?  a  review  of  the  ineﬃcacy  problem  and  existing  predictors  for  successful  eeg
  neurofeedback learning. <span 
class="ecsi-1200">Neuroscience</span>, 2017. doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.neuroscience.2016.</span>
  <span 
class="ecrm-1200">12.050</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XArnold2014"></a><span class="bibsp">   </span></span>L. E.  Arnold,  N. Lofthouse,  S. Hersch,  X. Pan,  E. Hurt,  B. Bates,  K. Kassouf,  S. Moone,
  and C. Grantier.   Eeg neurofeedback for attention-deﬁcit/hyperactivity disorder: Double-blind
  sham-controlled  randomized  pilot  feasibility  trial.   <span 
class="ecsi-1200">Journal  of  Atention  Disorder</span>,  2014.   doi:
  <span 
class="ecrm-1200">https://doi.org/10.1177/1087054712446173</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XArns2009"></a><span class="bibsp">   </span></span>M. Arns,  S. de Ridder,  U. Strehl,  M. Breteler,  and  A. Coenen.   Eﬃcacy  of  neurofeedback
  treatment in adhd: the eﬀects on inattention, impulsivity and hyperactivity: a meta-analysis.
  <span 
class="ecsi-1200">Clinical   EEG   and   neuroscience</span>,   40(3):180–189,   2009.      doi:   <span 
class="ecrm-1200">https://doi.org/10.1177/</span>
  <span 
class="ecrm-1200">155005940904000311</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XArns2013"></a><span class="bibsp">   </span></span>M. Arns,  C. K.  Conners,  and  H. C.  Kraemer.   A  decade  of  eeg  theta/beta  ratio  research
  in  adhd:  a  meta-analysis.   <span 
class="ecsi-1200">Journal  of  attention  disorders</span>,  17(5):374–383,  2013.   doi:  <span 
class="ecrm-1200">https:</span>
  <span 
class="ecrm-1200">//doi.org/10.1177/1087054712460087</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XArns2014"></a><span class="bibsp">   </span></span>M. Arns, H. Heinrich, and U. Strehl. Evaluation of neurofeedback in adhd: the long and winding
  road. <span 
class="ecsi-1200">Biological psychology</span>, 95:108–115, 2014. doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.biopsycho.2013.</span>
  <span 
class="ecrm-1200">11.013</span>.
                                                                                            
                                                                                            
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XArns2015"></a><span class="bibsp">   </span></span>M. Arns,  H. Heinrich,  T. Ros,  A. Rothenberger,  and  U. Strehl.    Neurofeedback  in  adhd.
  <span 
class="ecsi-1200">Frontiers in human neuroscience</span>, 9:602, 2015. doi: <span 
class="ecrm-1200">https://doi.org/10.3389/fnhum.2015.00602</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBakhshayesh2011"></a><span class="bibsp">   </span></span>A. R. Bakhshayesh, S. Hänsch, A. Wyschkon, M. J. Rezai, and G. Esser.  Neurofeedback in
  adhd: a single-blind randomized controlled trial. <span 
class="ecsi-1200">European child &#x0026; adolescent psychiatry</span>, 20(9):
  481, 2011. doi: <span 
class="ecrm-1200">https://doi.org/10.1007/s00787-011-0208-y</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBanaschewski2007"></a><span class="bibsp">   </span></span>T. Banaschewski and D. Brandeis. Annotation: what electrical brain activity tells us about brain
  function that other techniques cannot tell us–a child psychiatric perspective.  <span 
class="ecsi-1200">Journal of Child</span>
  <span 
class="ecsi-1200">Psychology and Psychiatry</span>, 48(5):415–435, 2007.   doi: <span 
class="ecrm-1200">https://doi.org/10.1111/j.1469-7610.</span>
  <span 
class="ecrm-1200">2006.01681.x</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBarkley1991"></a><span class="bibsp">   </span></span>R. A. Barkley.  The ecological validity of laboratory and analogue assessment methods of adhd
  symptoms. <span 
class="ecsi-1200">Journal of abnormal child psychology</span>, 19(2):149–178, 1991.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBarry2002"></a><span class="bibsp">   </span></span>T. D.   Barry,   R. D.   Lyman,   and   L. G.   Klinger.       Academic   underachievement   and
  attention-deﬁcit/hyperactivity  disorder:  The  negative  impact  of  symptom  severity  on  school
  performance. <span 
class="ecsi-1200">Journal of school psychology</span>, 40(3):259–283, 2002. doi: <span 
class="ecrm-1200">https://doi.org/10.1016/</span>
  <span 
class="ecrm-1200">S0022-4405(02)00100-0</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBaumeister2016"></a><span class="bibsp">   </span></span>S. Baumeister,  I. Wolf,  N. Holz,  R. Boecker-Schlier,  N. Adamo,  M. Holtmann,  M. Ruf,
  T. Banaschewski, S. Hohmann, and D. Brandeis.  Neurofeedback training eﬀects on inhibitory
  brain activation in adhd: A matter of learning?  <span 
class="ecsi-1200">Neuroscience</span>, 2016.  doi: <span 
class="ecrm-1200">https://doi.org/10.</span>
  <span 
class="ecrm-1200">1016/j.neuroscience.2016.09.025</span>.
                                                                                            
                                                                                            
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBeauregard2006"></a><span class="bibsp">   </span></span>M. Beauregard  and  J. Levesque.    Functional  magnetic  resonance  imaging  investigation  of
  the eﬀects of neurofeedback training on the neural bases of selective attention and response
  inhibition in children with attention-deﬁcit/hyperactivity disorder. <span 
class="ecsi-1200">Applied psychophysiology and</span>
  <span 
class="ecsi-1200">biofeedback</span>, 31(1):3–20, 2006. doi: <span 
class="ecrm-1200">https://doi.org/10.1007/s10484-006-9001-y</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBelanger2009"></a><span class="bibsp">   </span></span>S. A. Bélanger, M. Vanasse, S. Spahis, M.-P. Sylvestre, S. Lippé, F. l’Heureux, P. Ghadirian,
  C.-M. Vanasse, and E. Levy.  Omega-3 fatty acid treatment of children with attention-deﬁcit
  hyperactivity disorder: A randomized, double-blind, placebo-controlled study. <span 
class="ecsi-1200">Paediatrics &#x0026; child</span>
  <span 
class="ecsi-1200">health</span>, 14(2):89–98, 2009. doi: <span 
class="ecrm-1200">https://doi.org/10.1093/pch/14.2.89</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBerger1929"></a><span class="bibsp">   </span></span>H. Berger.    Über  das  elektrenkephalogramm  des  menschen.    <span 
class="ecsi-1200">Archiv  f</span><span 
class="ecsi-1200">ü</span><span 
class="ecsi-1200">r  psychiatrie  und</span>
  <span 
class="ecsi-1200">nervenkrankheiten</span>, 87(1):527–570, 1929.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBink2014"></a><span class="bibsp">   </span></span>M. Bink, C. van Nieuwenhuizen, A. Popma, I. L. Bongers, and G. J. M. van Boxtel. Behavioral
  eﬀects of neurofeedback in adolescents with adhd: a randomized controlled trial. <span 
class="ecsi-1200">European Child</span>
  <span 
class="ecsi-1200">and Adolescent Psychiatry</span>, 2014. doi: <span 
class="ecrm-1200">https://doi.org/10.1007/s00787-014-0655-3</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBirbaumer1991"></a><span class="bibsp">   </span></span>N. Birbaumer.    Clinical-psychological  treatment  of  epileptic  seizures:  a  controlled  study.
  <span 
class="ecsi-1200">Perspectives and promises in clinical psychology</span>, 1991.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBluschke2016"></a><span class="bibsp">   </span></span>A. Bluschke, F. Broschwitz, S. Kohl, V. Roessner, and C. Beste.  The neuronal mechanisms
  underlying improvement of impulsivity in adhd by theta/beta neurofeedback.  <span 
class="ecsi-1200">Scientiﬁc reports</span>,
  6:31178, 2016. doi: <span 
class="ecrm-1200">https://doi.org/10.1038/srep31178</span>.
  </p>
                                                                                            
                                                                                            
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XRolandLeBouedec"></a><span class="bibsp">   </span></span>R. L. Bouëdec. Mind your brain, un jeu pour entrainer le cerveau. <span 
class="ecsi-1200">Le Mag</span>, 2017.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XBussalb2018"></a><span class="bibsp">   </span></span>A. Bussalb.                                              Factors                inﬂuencing                nfb.
  <a 
href="https://github.com/AuroreBussalb/meta-analysis-statistical-tools" class="url" ><span 
class="ectt-1200">https://github.com/AuroreBussalb/meta-analysis-statistical-tools</span></a>, 2018a.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSupplementalmaterial"></a><span class="bibsp">   </span></span>A. Bussalb. Supplemental material. <a 
href="https://github.com/AuroreBussalb/meta-analysis-statistical-tools/blob/master/documentation/article-latex-source/supplemental_material.pdf" class="url" ><span 
class="ectt-1200">https://github.com/AuroreBussalb/meta-analysis-statistical-tools/blob/master/documentation/article-latex-source/supplemental_material.pdf</span></a>,
  2018b.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XChristiansen2014"></a><span class="bibsp">   </span></span>H. Christiansen, V. Reh, M. H. Schmidt, and W. Rief.  Slow cortical potential neurofeedback
  and self-management training in outpatient care for children with adhd: study protocol and ﬁrst
  preliminary results of a randomized controlled trial.  <span 
class="ecsi-1200">Frontiers in human neuroscience</span>, 8, 2014.
  doi: <span 
class="ecrm-1200">https://doi.org/10.3389/fnhum.2014.00943</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XRevMan"></a><span class="bibsp">   </span></span>Cochrane Collaboration. Revman 5.1, 2011.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XCohen1988"></a><span class="bibsp">   </span></span>J. Cohen.  <span 
class="ecsi-1200">Statistical power analysis for the behavioral sciences 2nd edn</span>.  Erlbaum Associates,
  Hillsdale, 1988.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XCollett2003"></a><span class="bibsp">   </span></span>B. R. Collett, J. L. Ohan, and K. M. Myers. Ten-year review of rating scales. v: scales assessing
  attention-deﬁcit/hyperactivity disorder. <span 
class="ecsi-1200">Journal of the American Academy of Child &#x0026; Adolescent</span>
  <span 
class="ecsi-1200">Psychiatry</span>, 42(9):1015–1037, 2003.  doi: <span 
class="ecrm-1200">https://doi.org/10.1097/01.CHI.0000070245.24125.</span>
  <span 
class="ecrm-1200">B6</span>.
  </p>
                                                                                            
                                                                                            
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XConners2008"></a><span class="bibsp">   </span></span>C. K. Conners. Conners 3. MHS, 2008.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XConners1998"></a><span class="bibsp">   </span></span>C. K. Conners, G. Sitarenios, J. D. Parker, and J. N. Epstein.   The revised conners’ parent
  rating scale (cprs-r): factor structure, reliability, and criterion validity.  <span 
class="ecsi-1200">Journal of abnormal child</span>
  <span 
class="ecsi-1200">psychology</span>, 26(4):257–268, 1998.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XCooper2011"></a><span class="bibsp">   </span></span>W. O. Cooper, L. A. Habel, C. M. Sox, K. A. Chan, P. G. Arbogast, T. C. Cheetham, K. T.
  Murray, V. P. Quinn, C. M. Stein, S. T. Callahan, et al. Adhd drugs and serious cardiovascular
  events in children and young adults. <span 
class="ecsi-1200">New England Journal of Medicine</span>, 365(20):1896–1904, 2011.
  doi: <span 
class="ecrm-1200">https://doi.org/10.1056/NEJMoa1110212</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XCortese2016"></a><span class="bibsp">   </span></span>S. Cortese,  M. Ferrin,  D. Brandeis,  M. Holtmann,  P. Aggensteiner,  D. Daley,  P. Santosh,
  E. Simonoﬀ, J. Stevenson, A. Stringaris, et al. Neurofeedback for attention-deﬁcit/hyperactivity
  disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled
  trials. <span 
class="ecsi-1200">Journal of the American Academy of Child &#x0026; Adolescent Psychiatry</span>, 55(6):444–455, 2016.
  doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.jaac.2016.03.007</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XDeilami2016"></a><span class="bibsp">   </span></span>M. Deilami,   A. Jahandideh,   Y. Kazemnejad,   Y. Fakour,   S. Alipoor,   F. Rabiee,   G. S.
  Pournesaie, R. N. Heidari, and S. A. Mosavi.  The eﬀect of neurofeedback therapy on reducing
  symptoms associated with attention deﬁcit hyperactivity disorder: A case series study. <span 
class="ecsi-1200">Basic and</span>
  <span 
class="ecsi-1200">clinical neuroscience</span>, 7(2):167, 2016. doi: <span 
class="ecrm-1200">https://doi.org/10.15412/J.BCN.03070211</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XDrechsler2007"></a><span class="bibsp">   </span></span>R. Drechsler,  M. Straub,  M. Doehnert,  H. Heinrich,  H.-C.  Steinhausen,  and  D. Brandeis.
  Controlled evaluation of a neurofeedback training of slow cortical potentials in children with
  attention deﬁcit/hyperactivity disorder (adhd).  <span 
class="ecsi-1200">Behavioral and brain functions</span>, 3(1):35, 2007.
  doi: <span 
class="ecrm-1200">https://doi.org/10.1186/1744-9081-3-35</span>.
                                                                                            
                                                                                            
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XDuPaul1998"></a><span class="bibsp">   </span></span>C. DuPaul,  Barkley.   Stimulants.   <span 
class="ecsi-1200">Attention-deﬁcit  hyperactivity  disorder:  A  handbook  for</span>
  <span 
class="ecsi-1200">diagnosis and treatment</span>, pages 510–551, 1998.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XDuric2012"></a><span class="bibsp">   </span></span>N. S. Duric, J. Assmus, D. Gundersen, and I. B. Elgen.  Neurofeedback for the treatment of
  children and adolescents with adhd: a randomized and controlled clinical trial using parental
  reports. <span 
class="ecsi-1200">BMC psychiatry</span>, 12(1):107, 2012. doi: <span 
class="ecrm-1200">https://doi.org/10.1186/1471-244X-12-107</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XDurup1935"></a><span class="bibsp">   </span></span>G. Durup   and   A. Fessard.       I.   l’électrencéphalogramme   de   l’homme.   observations
  psycho-physiologiques relatives à l’action des stimuli visuels et auditifs. <span 
class="ecsi-1200">L’ann</span><span 
class="ecsi-1200">é</span><span 
class="ecsi-1200">e psychologique</span>,
  36(1):1–32, 1935.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XEemagine"></a><span class="bibsp">   </span></span>Eemagine<span 
class="cmsy-10x-x-120">©</span>. Eemagine. <a 
href="http://www.eemagine.com/" >.</a>
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XEnriquez2017"></a><span class="bibsp">   </span></span>S. Enriquez-Geppert,  R. J.  Huster,  and  C. S.  Herrmann.   Eeg-neurofeedback  as  a  tool  to
  modulate cognition and behavior: a review tutorial. <span 
class="ecsi-1200">Frontiers in human neuroscience</span>, 11:51, 2017.
  doi: <span 
class="ecrm-1200">https://doi.org/10.3389/fnhum.2017.00051</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XEpstein2012"></a><span class="bibsp">   </span></span>J. N. Epstein and M. D. Weiss. Assessing treatment outcomes in attention-deﬁcit/hyperactivity
  disorder: a narrative review.  <span 
class="ecsi-1200">The primary care companion for CNS disorders</span>, 14(6), 2012.  doi:
  <span 
class="ecrm-1200">https://doi.org/10.4088/PCC.11r01336</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XEscolano2014"></a><span class="bibsp">   </span></span>C. Escolano, M. Navarro-Gil, J. Garcia-Campayo, M. Congedo, and J. Minguez. The eﬀects of
                                                                                            
                                                                                            
  individual upper alpha neurofeedback in adhd: an open-label pilot study. <span 
class="ecsi-1200">Applied psychophysiology</span>
  <span 
class="ecsi-1200">and biofeedback</span>, 39(3-4):193–202, 2014. doi: <span 
class="ecrm-1200">https://doi.org/10.1007/s10484-014-9257-6</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XFaraone2006"></a><span class="bibsp">   </span></span>S. V. Faraone, J. Biederman, and E. Mick.   The age-dependent decline of attention deﬁcit
  hyperactivity  disorder:  a  meta-analysis  of  follow-up  studies.   <span 
class="ecsi-1200">Psychological  medicine</span>,  36(2):
  159–165, 2006. doi: <span 
class="ecrm-1200">https://doi.org/10.1017/S003329170500471X</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XForbes1998"></a><span class="bibsp">   </span></span>G. B. Forbes.  Clinical utility of the test of variables of attention (tova) in the diagnosis of
  attention-deﬁcit/hyperactivity disorder. <span 
class="ecsi-1200">Journal of clinical psychology</span>, 54(4):461–476, 1998. doi:
  <span 
class="ecrm-1200">https://doi.org/10.1002/(SICI)1097-4679(199806)54:4&#x003C;461::AID-JCLP8&#x003E;3.0.CO;2-Q</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XFouillen2017"></a><span class="bibsp">   </span></span>M. Fouillen, E. Maby, L. Le Career, V. Herbillon, and J. Mattout.  Erp-based bci for children
  with adhd. 2017.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XFuchs2003"></a><span class="bibsp">   </span></span>T. Fuchs,  N. Birbaumer,  W. Lutzenberger,  J. H.  Gruzelier,  and  J. Kaiser.   Neurofeedback
  treatment   for   attention-deﬁcit/hyperactivity   disorder   in   children:   a   comparison   with
  methylphenidate. <span 
class="ecsi-1200">Applied psychophysiology and biofeedback</span>, 28(1):1–12, 2003.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XGevensleben2009"></a><span class="bibsp">   </span></span>H. Gevensleben,   B. Holl,   B. Albrecht,   C. Vogel,   D. Schlamp,   O. Kratz,   P. Studer,
  A. Rothenberger, G. H. Moll, and H. Heinrich.  Is neurofeedback an eﬃcacious treatment for
  adhd? a randomised controlled clinical trial. <span 
class="ecsi-1200">Journal of Child Psychology and Psychiatry</span>, 50(7):
  780–789, 2009. doi: <span 
class="ecrm-1200">https://doi.org/10.1111/j.1469-7610.2008.02033.x</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XHarpin2005"></a><span class="bibsp">   </span></span>V. A. Harpin.   The eﬀect of adhd on the life of an individual, their family, and community
                                                                                            
                                                                                            
  from preschool to adult life.   <span 
class="ecsi-1200">Archives of disease in childhood</span>, 90(suppl 1):i2–i7, 2005.   doi:
  <span 
class="ecrm-1200">http://dx.doi.org/10.1136/adc.2004.059006</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XHeinrich2004"></a><span class="bibsp">   </span></span>H. Heinrich, H. Gevensleben, F. J. Freisleder, G. H. Moll, and A. Rothenberger.  Training of
  slow cortical potentials in attention-deﬁcit/hyperactivity disorder: evidence for positive behavioral
  and neurophysiological eﬀects. <span 
class="ecsi-1200">Biological psychiatry</span>, 55(7):772–775, 2004. doi: <span 
class="ecrm-1200">https://doi.org/</span>
  <span 
class="ecrm-1200">10.1016/j.biopsych.2003.11.013</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XHoltmann2009"></a><span class="bibsp">   </span></span>M. Holtmann, D. Grasmann, E. Cionek-Szpak, V. Hager, N. Panzner, A. Beyer, F. Poustka,
  and C. Stadler. Speziﬁsche wirksamkeit von neurofeedback auf die impulsivität bei adhs. <span 
class="ecsi-1200">Kindheit</span>
  <span 
class="ecsi-1200">und Entwicklung</span>, 18(2):95–104, 2009. doi: <span 
class="ecrm-1200">https://doi.org/10.1026/0942-5403.18.2.95</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XHoltmann2014"></a><span class="bibsp">   </span></span>M. Holtmann,  B. Pniewski,  D. Wachtlin,  S. Wörz,  and  U. Strehl.     Neurofeedback  in
  children with attention-deﬁcit/hyperactivity disorder (adhd)–a controlled multicenter study of a
  non-pharmacological treatment approach. <span 
class="ecsi-1200">BMC pediatrics</span>, 14(1):202, 2014.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XISO-60601-2-26:2012"></a><span class="bibsp">   </span></span>International          Electrotechnical          Commission.                           60601-2-26:2012.
  <a 
href="https://webstore.iec.ch/publication/2637#additionalinfo" class="url" ><span 
class="ectt-1200">https://webstore.iec.ch/publication/2637#additionalinfo</span></a>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XJames2013"></a><span class="bibsp">   </span></span>G. James, D. Witten, T. Hastie, and R. Tibshirani.   <span 
class="ecsi-1200">An introduction to statistical learning</span>,
  volume 112. Springer, 2013.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XJanzen1995"></a><span class="bibsp">   </span></span>T. Janzen,  K. Graap,  S. Stephanson,  W. Marshall,  and  G. Fitzsimmons.    Diﬀerences  in
  baseline eeg measures for add and normally achieving preadolescent males.   <span 
class="ecsi-1200">Biofeedback and</span>
  <span 
class="ecsi-1200">self-Regulation</span>, 20(1):65–82, 1995.
                                                                                            
                                                                                            
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XJensen1999"></a><span class="bibsp">   </span></span>P. S.   Jensen.       A   14-month   randomized   clinical   trial   of   treatment   strategies   for
  attention-deﬁcit/hyperactivity disorder. <span 
class="ecsi-1200">Archives of general psychiatry</span>, 56(12):1073–1086, 1999.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XJeunet2018"></a><span class="bibsp">   </span></span>C. Jeunet, F. Lotte, J.-M. Batail, P. Philip, and J.-A. M. Franchi.  Using recent bci literature
  to deepen our understanding of clinical neurofeedback: A short review. <span 
class="ecsi-1200">Neuroscience</span>, 2018. doi:
  <span 
class="ecrm-1200">https://doi.org/10.1016/j.neuroscience.2018.03.013</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XKropotov2005"></a><span class="bibsp">   </span></span>J. D. Kropotov, V. A. Grin-Yatsenko, V. A. Ponomarev, L. S. Chutko, E. A. Yakovenko, and
  I. S. Nikishena. Erps correlates of eeg relative beta training in adhd children. <span 
class="ecsi-1200">International journal</span>
  <span 
class="ecsi-1200">of psychophysiology</span>, 55(1):23–34, 2005. doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.ijpsycho.2004.05.011</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="Xle2014"></a><span class="bibsp">   </span></span>H. H. Le, P. Hodgkins, M. J. Postma, J. Kahle, V. Sikirica, J. Setyawan, M. H. Erder, and
  J. A. Doshi. Economic impact of childhood/adolescent adhd in a european setting: the netherlands
  as  a  reference  case.   <span 
class="ecsi-1200">European  child  &#x0026;  adolescent  psychiatry</span>,  23(7):587–598,  2014.   doi:
  <span 
class="ecrm-1200">https://doi.org/10.1007/s00787-013-0477-8</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XLee2017"></a><span class="bibsp">   </span></span>E.-J.  Lee  and  C.-H.  Jung.    Additive  eﬀects  of  neurofeedback  on  the  treatment  of  adhd:
  A  randomized  controlled  study.   <span 
class="ecsi-1200">Asian  Journal  of  Psychiatry</span>,  25:16–21,  2017.   doi:  <span 
class="ecrm-1200">https:</span>
  <span 
class="ecrm-1200">//doi.org/10.1016/j.ajp.2016.09.002</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XLeins2007"></a><span class="bibsp">   </span></span>U. Leins, G. Goth, T. Hinterberger, C. Klinger, N. Rumpf, and U. Strehl.  Neurofeedback for
  children with adhd: a comparison of scp and theta/beta protocols. <span 
class="ecsi-1200">Applied psychophysiology and</span>
  <span 
class="ecsi-1200">biofeedback</span>, 32(2):73–88, 2007. doi: <span 
class="ecrm-1200">https://doi.org/10.1007/s10484-007-9031-0</span>.
  </p>
                                                                                            
                                                                                            
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XLi2013"></a><span class="bibsp">   </span></span>L. Li,  L. Yang,  C. Zhuo,  and  Y.-F.  Wang.   A  randomised  controlled  trial  of  combined  eeg
  feedback and methylphenidate therapy for the treatment of adhd. <span 
class="ecsi-1200">Swiss Med. Wkly</span>, 143:w13838,
  2013. doi: <span 
class="ecrm-1200">https://doi.org/10.4414/smw.2013.13838</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XLinden1996"></a><span class="bibsp">   </span></span>M. Linden, T. Habib, and V. Radojevic. A controlled study of the eﬀects of eeg biofeedback on
  cognition and behavior of children with attention deﬁcit disorder and learning disabilities. <span 
class="ecsi-1200">Applied</span>
  <span 
class="ecsi-1200">Psychophysiology and Biofeedback</span>, 21(1):35–49, 1996.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XLofthouse2012"></a><span class="bibsp">   </span></span>N. Lofthouse, L. E. Arnold, S. Hersch, E. Hurt, and R. DeBeus.  A review of neurofeedback
  treatment for pediatric adhd.  <span 
class="ecsi-1200">Journal of Attention Disorders</span>, 2012.  doi: <span 
class="ecrm-1200">https://doi.org/10.</span>
  <span 
class="ecrm-1200">1177/1087054711427530</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XLoo2005"></a><span class="bibsp">   </span></span>S. K. Loo and R. A. Barkley.  Clinical utility of eeg in attention deﬁcit hyperactivity disorder.
  <span 
class="ecsi-1200">Applied Neuropsychology</span>, 12:64–76, 2005. doi: <span 
class="ecrm-1200">https://doi.org/10.1007/s13311-012-0131-z</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="Xloo2017"></a><span class="bibsp">   </span></span>S. K.  Loo,  J. J.  McGough,  J. T.  McCracken,  and  S. L.  Smalley.   Parsing  heterogeneity  in
  attention-deﬁcit hyperactivity disorder using eeg-based subgroups.  <span 
class="ecsi-1200">Journal of Child Psychology</span>
  <span 
class="ecsi-1200">and Psychiatry</span>, 2017. doi: <span 
class="ecrm-1200">https://doi.org/10.1111/jcpp.12814</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XLubar1976"></a><span class="bibsp">   </span></span>J. F. Lubar and M. N. Shouse.  Eeg and behavioral changes in a hyperkinetic child concurrent
  with training of the sensorimotor rhythm (smr). <span 
class="ecsi-1200">Biofeedback and Self-regulation</span>, 1(3):293–306,
  1976.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMarzbani2016"></a><span class="bibsp">   </span></span>H. Marzbani, H. R. Marateb, and M. Mansourian.  Neurofeedback: a comprehensive review on
                                                                                            
                                                                                            
  system design, methodology and clinical applications.  <span 
class="ecsi-1200">Basic and clinical neuroscience</span>, 7(2):143,
  2016. doi: <span 
class="ecrm-1200">https://doi.org/10.15412/J.BCN.03070208</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMatouvsek1984"></a><span class="bibsp">   </span></span>M. Matoušek, P. Rasmussen, and C. Gillberg. Eeg frequency analysis in children with so-called
  minimal  brain  dysfunction  and  related  disorders.   In  <span 
class="ecsi-1200">Neurophysiological  Correlates  of  Mental</span>
  <span 
class="ecsi-1200">Disorders</span>, volume 15, pages 102–108. Karger Publishers, 1984.  doi: <span 
class="ecrm-1200">https://doi.org/10.1159/</span>
  <span 
class="ecrm-1200">000410508</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMaurizio2014"></a><span class="bibsp">   </span></span>S. Maurizio,   M. D.   Liechti,   H. Heinrich,   L. Jäncke,   H.-C.   Steinhausen,   S. Walitza,
  D. Brandeis, and R. Drechsler. Comparing tomographic eeg neurofeedback and emg biofeedback
  in children with attention-deﬁcit/hyperactivity disorder.  <span 
class="ecsi-1200">Biological psychology</span>, 95:31–44, 2014.
  doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.biopsycho.2013.10.008</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMeisel2014"></a><span class="bibsp">   </span></span>V. Meisel, M. Servera, G. Garcia-Banda, E. Cardo, and I. Moreno.  Reprint of “neurofeedback
  and standard pharmacological intervention in adhd: a randomized controlled trial with six-month
  follow-up”. <span 
class="ecsi-1200">Biological psychology</span>, 95:116–125, 2014. doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.biopsycho.</span>
  <span 
class="ecrm-1200">2013.09.009</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMicoulaud2014"></a><span class="bibsp">   </span></span>J.-A. Micoulaud-Franchi, P. A. Geoﬀroy, G. Fond, R. Lopez, S. Bioulac, and P. Philip.  Eeg
  neurofeedback  treatments  in  children  with  adhd:  an  updated  meta-analysis  of  randomized
  controlled trials. <span 
class="ecsi-1200">Frontiers in human neuroscience</span>, 8, 2014. doi: <span 
class="ecrm-1200">https://doi.org/10.3389/fnhum.</span>
  <span 
class="ecrm-1200">2014.00906</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMicoulaud2016"></a><span class="bibsp">   </span></span>J.-A.    Micoulaud-Franchi,    F. Salvo,    S. Bioulac,    and    T. Fovet.          Neurofeedbach
  in attention-deﬁcit/hyperactivity disorder: Eﬃcacy. <span 
class="ecsi-1200">Journal of the American Academy of Child &#x0026;</span>
  <span 
class="ecsi-1200">Adolescent Psychiatry</span>, 2016. doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.jaac.2016.09.493</span>.
                                                                                            
                                                                                            
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMinder2018"></a><span class="bibsp">   </span></span>F. Minder,   A. Zuberer,   D. Brandeis,   and   R. Drechsler.      Informant-related   eﬀects   of
  neurofeedback and cognitive training in children with adhd including a waiting control phase: a
  randomized-controlled trial.  <span 
class="ecsi-1200">European child &#x0026; adolescent psychiatry</span>, pages 1–12, 2018.  doi:
  <span 
class="ecrm-1200">https://doi.org/10.1007/s00787-018-1116-1</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMohagheghi2017"></a><span class="bibsp">   </span></span>A. Mohagheghi,  S. Amiri,  N. Moghaddasi Bonab,  G. Chalabianloo,  S. G.  Noorazar,  S. M.
  Tabatabaei, and S. Farhang. A randomized trial of comparing the eﬃcacy of two neurofeedback
  protocols  for  treatment  of  clinical  and  cognitive  symptoms  of  adhd:  Theta  suppression/beta
  enhancement and theta suppression/alpha enhancement.  <span 
class="ecsi-1200">BioMed Research International</span>, 2017,
  2017. doi: <span 
class="ecrm-1200">https://doi.org/10.1155/2017/3513281</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMohammadi2015"></a><span class="bibsp">   </span></span>M. R. Mohammadi, N. Malmir, A. Khaleghi, and M. Aminiorani.  Comparison of sensorimotor
  rhythm (smr) and beta training on selective attention and symptoms in children with attention
  deﬁcit/hyperactivity disorder (adhd): A trend report.  <span 
class="ecsi-1200">Iranian journal of psychiatry</span>, 10(3):165,
  2015.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMonastra2005"></a><span class="bibsp">   </span></span>V. J.  Monastra.    Electroencephalographic  biofeedback  (neurotherapy)  as  a  treatment  for
  attention deﬁcit hyperactivity disorder: rationale and empirical foundation. <span 
class="ecsi-1200">Child and Adolescent</span>
  <span 
class="ecsi-1200">Psychiatric Clinics of North America</span>, 14(1):55–82, 2005.  doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.chc.</span>
  <span 
class="ecrm-1200">2004.07.004</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMonastra2002"></a><span class="bibsp">   </span></span>V. J.  Monastra,  D. M.  Monastra,  and  S. George.    The  eﬀects  of  stimulant  therapy,  eeg
  biofeedback,  and  parenting  style  on  the  primary  symptoms  of  attention-deﬁcit/hyperactivity
  disorder. <span 
class="ecsi-1200">Applied psychophysiology and biofeedback</span>, 27(4):231–249, 2002.
  </p>
                                                                                            
                                                                                            
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMontgomery2012"></a><span class="bibsp">   </span></span>D. C. Montgomery, E. A. Peck, and G. G. Vining.  <span 
class="ecsi-1200">Introduction to linear regression analysis</span>,
  volume 821. John Wiley &#x0026; Sons, 2012.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XMowrer1960"></a><span class="bibsp">   </span></span>O. Mowrer.    <span 
class="ecsi-1200">Learning  theory  and  behavior.    </span>John  Wiley  &#x0026;  Sons  Inc,  1960.    doi:  <span 
class="ecrm-1200">http:</span>
  <span 
class="ecrm-1200">//dx.doi.org/10.1037/10802-000</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XNarad2015"></a><span class="bibsp">   </span></span>M. E.  Narad,  A. A.  Garner,  J. L.  Peugh,  L. Tamm,  T. N.  Antonini,  K. M.  Kingery,  J. O.
  Simon, and J. N. Epstein.  Parent–teacher agreement on adhd symptoms across development.
  <span 
class="ecsi-1200">Psychological assessment</span>, 27(1):239, 2015. doi: <span 
class="ecrm-1200">https://doi.org/10.1037/a0037864</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XNeba"></a><span class="bibsp">   </span></span>Neba                         Health.                                                                        Neba.
  <a 
href="https://shop.nebahealth.com/products/neba-fda-cleared-brainwave-adhd-assessment-aid" >https://shop.nebahealth.com/products/neba-fda-cleared-brainwave-adhd-assessment-aid</a>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XTheraPrax"></a><span class="bibsp">   </span></span>NeuroCare.                                                                   Thera                       Prax®.
  <a 
href="https://www.neurocaregroup.com/neuroconn-thera-prax.html" class="url" ><span 
class="ectt-1200">https://www.neurocaregroup.com/neuroconn-thera-prax.html</span></a>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XOgrim2013"></a><span class="bibsp">   </span></span>G. Ogrim  and  K. A.  Hestad.    Eﬀects  of  neurofeedback  versus  stimulant  medication  in
  attention-deﬁcit/hyperactivity disorder: a randomized pilot study. <span 
class="ecsi-1200">Journal of child and adolescent</span>
  <span 
class="ecsi-1200">psychopharmacology</span>, 23(7):448–457, 2013. doi: <span 
class="ecrm-1200">https://doi.org/10.1089/cap.2012.0090</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XPedregosa2011"></a><span class="bibsp">   </span></span>F. Pedregosa,  G. Varoquaux,  A. Gramfort,  V. Michel,  B. Thirion,  O. Grisel,  M. Blondel,
  P. Prettenhofer, R. Weiss, V. Dubourg, et al. Scikit-learn: Machine learning in python. <span 
class="ecsi-1200">Journal</span>
  <span 
class="ecsi-1200">of machine learning research</span>, 12(Oct):2825–2830, 2011.
  </p>
                                                                                            
                                                                                            
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XQuinlan1986"></a><span class="bibsp">   </span></span>J. R. Quinlan. Induction of decision trees. <span 
class="ecsi-1200">Machine learning</span>, 1(1):81–106, 1986.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XReynolds1975"></a><span class="bibsp">   </span></span>G. S. Reynolds. A primer of operant conditioning, rev. 1975.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XRobertson1997"></a><span class="bibsp">   </span></span>I. H. Robertson, T. Manly, J. Andrade, B. T. Baddeley, and J. Yiend.  Oops!’: performance
  correlates  of  everyday  attentional  failures  in  traumatic  brain  injured  and  normal  subjects.
  <span 
class="ecsi-1200">Neuropsychologia</span>, 35(6):747–758, 1997. doi: <span 
class="ecrm-1200">https://doi.org/10.1016/S0028-3932(97)00015-8</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XRogala2016"></a><span class="bibsp">   </span></span>J. Rogala, K. Jurewicz, K. Paluch, E. Kublik, R. Cetnarski, and A. Wróbel.   The do’s and
  don’ts of neurofeedback training: a review of the controlled studies using healthy adults. <span 
class="ecsi-1200">Frontiers</span>
  <span 
class="ecsi-1200">in human neuroscience</span>, 10:301, 2016. doi: <span 
class="ecrm-1200">https://doi.org/10.3389/fnhum.2016.00301</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XRossiter1995"></a><span class="bibsp">   </span></span>D. T. R. Rossiter and T. J. La Vaque. A comparison of eeg biofeedback and psychostimulants
  in treating attention deﬁcit/hyperactivity disorders. <span 
class="ecsi-1200">Journal of Neurotherapy</span>, 1(1):48–59, 1995.
  doi: <span 
class="ecrm-1200">https://doi.org/10.1300/J184v01n01_07</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSeabold2010"></a><span class="bibsp">   </span></span>S. Seabold and J. Perktold. Statsmodels: Econometric and statistical modeling with python. In
  <span 
class="ecsi-1200">Proceedings of the 9th Python in Science Conference</span>, volume 57, page 61. SciPy society Austin,
  2010.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XShapiro2010"></a><span class="bibsp">   </span></span>E. S. Shapiro. <span 
class="ecsi-1200">Academic skills problems fourth edition workbook</span>. Guilford Press, 2010.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XShaw2005"></a><span class="bibsp">   </span></span>B. Shaw-Zirt, L. Popali-Lehane, W. Chaplin, and A. Bergman.  Adjustment, social skills, and
                                                                                            
                                                                                            
  self-esteem in college students with symptoms of adhd.  <span 
class="ecsi-1200">Journal of Attention Disorders</span>, 8(3):
  109–120, 2005. doi: <span 
class="ecrm-1200">https://doi.org/10.1177/1087054705277775</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSherlin2011"></a><span class="bibsp">   </span></span>L. H.  Sherlin,  M. Arns,  J. Lubar,  H. Heinrich,  C. Kerson,  U. Strehl,  and  M. B.  Sterman.
  Neurofeedback  and  basic  learning  theory:  implications  for  research  and  practice.   <span 
class="ecsi-1200">Journal  of</span>
  <span 
class="ecsi-1200">Neurotherapy</span>, 15(4):292–304, 2011.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSkinner1961"></a><span class="bibsp">   </span></span>B. F. Skinner. The operational analysis of psychological terms. 1961.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSollie2013"></a><span class="bibsp">   </span></span>H. Sollie, B. Larsson, and W.-T. Mørch. Comparison of mother, father, and teacher reports of
  adhd core symptoms in a sample of child psychiatric outpatients. <span 
class="ecsi-1200">Journal of Attention Disorders</span>,
  17(8):699–710, 2013. doi: <span 
class="ecrm-1200">https://doi.org/10.1177/1087054711436010</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSonuga-Barke2013"></a><span class="bibsp">   </span></span>E. J. Sonuga-Barke, D. Brandeis, S. Cortese, D. Daley, M. Ferrin, M. Holtmann, J. Stevenson,
  M. Danckaerts,  S. van der  Oord,  M. Döpfner,  R. W.  Dittmann,  E. Simonoﬀ,  A. Zuddas,
  T. Banaschewski, J. Buitelaar, D. Coghill, C. Hollis, E. Konofal, M. Lecendreux, I. C. Wong,
  and J. Sergeant. Nonpharmacological interventions for adhd: Systematic review and meta-analyses
  of randomized controlled trials of dietary and psychological treatments.  <span 
class="ecsi-1200">American Journal of</span>
  <span 
class="ecsi-1200">Psychiatry</span>, 2013. doi: <span 
class="ecrm-1200">https://doi.org/10.1176/appi.ajp.2012.12070991</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSteffert2010"></a><span class="bibsp">   </span></span>B. Steﬀert and T. Steﬀert. Neurofeedback and adhd. <span 
class="ecsi-1200">ADHD in practice</span>, 2(1):16–19, 2010.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSteiner2011"></a><span class="bibsp">   </span></span>N. J. Steiner, R. C. Sheldrick, D. Gotthelf, and E. C. Perrin. Computer-based attention training
  in the schools for children with attention deﬁcit/hyperactivity disorder: a preliminary trial. <span 
class="ecsi-1200">Clinical</span>
  <span 
class="ecsi-1200">pediatrics</span>, 50(7):615–622, 2011. doi: <span 
class="ecrm-1200">https://doi.org/10.1177/0009922810397887</span>.
                                                                                            
                                                                                            
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSteiner2014"></a><span class="bibsp">   </span></span>N. J. Steiner, E. C. Frenette, K. M. Rene, R. T. Brennan, and E. C. Perrin.  Neurofeedback
  and  cognitive  attention  training  for  children  with  attention-deﬁcit  hyperactivity  disorder  in
  schools.   <span 
class="ecsi-1200">Journal of Developmental &#x0026; Behavioral Pediatrics</span>, 35(1):18–27, 2014.   doi: <span 
class="ecrm-1200">https:</span>
  <span 
class="ecrm-1200">//doi.org/10.1097/DBP.0000000000000009</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSterman1974"></a><span class="bibsp">   </span></span>M. Sterman,  L. MacDonald,  and  R. K.  Stone.    Biofeedback  training  of  the  sensorimotor
  electroencephalogram rhythm in man: eﬀects on epilepsy.  <span 
class="ecsi-1200">Epilepsia</span>, 15(3):395–416, 1974.  doi:
  <span 
class="ecrm-1200">https://doi.org/10.1111/j.1528-1157.1974.tb04016.x</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XStorebo2015"></a><span class="bibsp">   </span></span>O. J.  Storebo,  H. B.  Krogh,  E. Ramstad,  C. R.  Moreira-Maia,  M. Holmskov,  M. Skoog,
  T. D. Nilausen, F. L. Magnusson, M. Zwi, D. Gillies, S. Rosendal, C. Groth, K. B. Rasmussen,
  D. Gauci,  R. Kirubakaran,  B. Forsbol,  E. Simonsen,  and  C. Gluud.    Methylphenidate  for
  attention-deﬁcit/hyperactivity disorder in children and adolescents: Cochrane systematic review
  with meta-analyses and trial sequential analyses of randomised clinical trials.  <span 
class="ecsi-1200">BMJ</span>, 2015.  doi:
  <span 
class="ecrm-1200">https://doi.org/10.1136/bmj.h5203</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XStrehl2006"></a><span class="bibsp">   </span></span>U. Strehl, U. Leins, G. Goth, C. Klinger, T. Hinterberger, and N. Birbaumer. Self-regulation of
  slow cortical potentials: a new treatment for children with attention-deﬁcit/hyperactivity disorder.
  <span 
class="ecsi-1200">Pediatrics</span>, 118(5):e1530–e1540, 2006. doi: <span 
class="ecrm-1200">https://doi.org/10.1542/peds.2005-2478</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XStrehl2017"></a><span class="bibsp">   </span></span>U. Strehl,  P. Aggensteiner,  D. Wachtlin,  D. Brandeis,  B. Albrecht,  M. Arana,  C. Bach,
  T. Banaschewski, T. Bogen, A. Flaig-Rohr, et al.  Neurofeedback of slow cortical potentials in
  children with attention-deﬁcit/hyperactivity disorder: A multicenter randomized trial controlling
  for unspeciﬁc eﬀects. <span 
class="ecsi-1200">Frontiers in human neuroscience</span>, 11, 2017. doi: <span 
class="ecrm-1200">https://doi.org/10.3389/</span>
  <span 
class="ecrm-1200">fnhum.2017.00135</span>.
  </p>
                                                                                            
                                                                                            
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XSwanson2001"></a><span class="bibsp">   </span></span>J. M. Swanson, H. C. Kraemer, S. P. Hinshaw, L. E. Arnold, C. K. Conners, H. B. Abikoﬀ,
  W. Clevenger, M. Davies, G. R. Elliott, L. L. Greenhill, et al.  Clinical relevance of the primary
  ﬁndings of the mta: success rates based on severity of adhd and odd symptoms at the end of
  treatment. <span 
class="ecsi-1200">Journal of the American Academy of Child &#x0026; Adolescent Psychiatry</span>, 40(2):168–179,
  2001. doi: <span 
class="ecrm-1200">https://doi.org/10.1097/00004583-200102000-00011</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XTaylor2014"></a><span class="bibsp">   </span></span>E. Taylor.  Uses and misuses of treatments for adhd. the second birgit olsson lecture.  <span 
class="ecsi-1200">Nordic</span>
  <span 
class="ecsi-1200">journal  of  psychiatry</span>,  68(4):236–242,  2014.    doi:  <span 
class="ecrm-1200">https://doi.org/10.3109/08039488.2013.</span>
  <span 
class="ecrm-1200">804118</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XDSM-4"></a><span class="bibsp">   </span></span>The American Psychiatric Association.  <span 
class="ecsi-1200">Diagnostic and Statistical Manual of Mental Disorders,</span>
  <span 
class="ecsi-1200">Fourth Edition (DSM-4)</span>, 4 edition, 2000.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XDSM-5"></a><span class="bibsp">   </span></span>The American Psychiatric Association.  <span 
class="ecsi-1200">Diagnostic and Statistical Manual of Mental Disorders,</span>
  <span 
class="ecsi-1200">Fifth Edition (DSM-5)</span>, 5 edition, 2013.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XTibshirani1996"></a><span class="bibsp">   </span></span>R. Tibshirani. Regression shrinkage and selection via the lasso. <span 
class="ecsi-1200">Journal of the Royal Statistical</span>
  <span 
class="ecsi-1200">Society. Series B (Methodological)</span>, pages 267–288, 1996.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XVanDongen2013"></a><span class="bibsp">   </span></span>M. van  Dongen-Boomsma,  M. A.  Vollebregt,  D. Slaats-Willemse,  and  J. K.  Buitelaar.    A
  randomized placebo-controlled trial of electroencephalographic (eeg) neurofeedback in children
  with  attention-deﬁcit/hyperactivity  disorder.   <span 
class="ecsi-1200">J  Clin  Psychiatry</span>,  74(8):821–827,  2013.   doi:
  <span 
class="ecrm-1200">https://doi.org/10.4088/JCP.12m08321</span>.
  </p>
                                                                                            
                                                                                            
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XVanDoren2017"></a><span class="bibsp">   </span></span>J. Van Doren,  H. Heinrich,  M. Bezold,  N. Reuter,  O. Kratz,  S. Horndasch,  M. Berking,
  T. Ros, H. Gevensleben, G. H. Moll, et al.  Theta/beta neurofeedback in children with adhd:
  Feasibility of a short-term setting and plasticity eﬀects. <span 
class="ecsi-1200">International Journal of Psychophysiology</span>,
  112:80–88, 2017. doi: <span 
class="ecrm-1200">https://doi.org/10.1016/j.ijpsycho.2016.11.004</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XVernon2004"></a><span class="bibsp">   </span></span>D. Vernon, A. Frick, and J. Gruzelier. Neurofeedback as a treatment for adhd: A methodological
  review with implications for future research.  <span 
class="ecsi-1200">Journal of Neurotherapy</span>, 8(2):53–82, 2004.  doi:
  <span 
class="ecrm-1200">https://doi.org/10.1300/J184v08n02_04</span>.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XWang2010"></a><span class="bibsp">   </span></span>Q. Wang,  O. Sourina,  and  M. K.  Nguyen.   Eeg-based&#x0022;  serious&#x0022;  games  design  for  medical
  applications. In <span 
class="ecsi-1200">Cyberworlds (cw), 2010 international conference on</span>, pages 270–276. IEEE, 2010.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XICD101993"></a><span class="bibsp">   </span></span>World Health Organization.   <span 
class="ecsi-1200">The ICD-10 classiﬁcation of mental and behavioural disorders:</span>
  <span 
class="ecsi-1200">diagnostic criteria for research</span>, volume 2. World Health Organization, 1993.
  </p>
  <p class="bibitem" ><span class="biblabel">
<a 
 id="XWorld-Medical-Association2000"></a><span class="bibsp">   </span></span>World Medical Association. <span 
class="ecsi-1200">The Declaration of Helsinki 52nd WMA General Assembly</span>. 2000.
</p>
  </div>
                                                                                            
                                                                                            
   <h3 class="likesectionHead"><a 
 id="x1-240005"></a>Figure captions</h3>
   <hr class="figure" /><div class="figure" 
>
                                                                                            
                                                                                            
<a 
 id="x1-240011"></a>
                                                                                            
                                                                                            
<!--l. 5--><p class="noindent" ><img 
src="figures/meta_review_factors_analysis_how_studies_are_included_no_colors_2-columns_fitting_ima.jpg" alt="PIC"  
 />
<br /> </p><div class="caption" 
><span class="id">Figure 1: </span><span  
class="content">Flow diagram of selection of studies (last search on December 14, 2017). The subset
(a) corresponds to the <a 
href="#XCortese2016">Cortese et al.</a>’s inclusion criteria without the requirement for the presence
of a control group. The number of patients is only equal to the subjects in the <a 
href="#glo:nfb">NFB</a> groups. The
subset (b) exactly corresponds to the studies included in <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>] and more recent
work meeting the same criteria. Here, the number of patients includes all patients whatever their
treatment group.</span></div><!--tex4ht:label?: x1-240011 -->
                                                                                            
                                                                                            
   </div><hr class="endfigure" />
   <hr class="figure" /><div class="figure" 
>
                                                                                            
                                                                                            
<a 
 id="x1-240022"></a>
                                                                                            
                                                                                            
<!--l. 16--><p class="noindent" ><img 
src="figures/meta_review_forest_plots_update_meta_analysis_our_choices_no_colors_2-columns_fitting_image.jpg" alt="PIC"  
 />
<br /> </p><div class="caption" 
><span class="id">Figure 2: </span><span  
class="content">Forest plots obtained on the dataset &#x0022;Update meta-analysis&#x0022; with the Python code. The
<a 
href="#glo:es">ES</a> presented here correspond to the between subject eﬀect size. A negative <a 
href="#glo:es">ES</a> is in favor of <a 
href="#glo:nfb">NFB</a>.
The blue squares correspond to the <a 
href="#glo:es">ES</a>, the blue diamond to the <a 
href="#glo:se">SE</a> and the green line to the 95%
conﬁdence interval.</span></div><!--tex4ht:label?: x1-240022 -->
                                                                                            
                                                                                            
   </div><hr class="endfigure" />
   <hr class="figure" /><div class="figure" 
>
                                                                                            
                                                                                            
<a 
 id="x1-240033"></a>
                                                                                            
                                                                                            
<!--l. 25--><p class="noindent" ><img 
src="figures/factors_analysis_decision_tree_results_no_colors_2-columns_fitting_image.jpg" alt="PIC"  
 />
<br /> </p><div class="caption" 
><span class="id">Figure 3: </span><span  
class="content">Decision Tree obtained: <a 
href="#glo:es">ES</a> corresponds to the within subject eﬀect size and k to the
number of studies. The criteria to minimize was the <a 
href="#glo:mse">MSE</a>. The importance of nodes and leafs is
decreasing from the root node.</span></div><!--tex4ht:label?: x1-240033 -->
                                                                                            
                                                                                            
   </div><hr class="endfigure" />
   <hr class="figure" /><div class="figure" 
>
                                                                                            
                                                                                            
<a 
 id="x1-240044"></a>
                                                                                            
                                                                                            
<!--l. 34--><p class="noindent" ><img 
src="figures/discussion_on_placebo_effect_colors_2-columns_fitting_image.jpg" alt="PIC"  
 />
<br /> </p><div class="caption" 
><span class="id">Figure 4: </span><span  
class="content">Pre-test and post-test scores (<!--l. 39--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mo 
class="MathClass-bin">±</mo></math>
standard  error)  given  by  Parents  (<a 
href="#glo:mprox">MPROX</a>)  in  blue  and  teachers  (<a 
href="#glo:pblind">PBLIND</a>)  in  green.  Two
conﬁgurations:  <span 
class="ecsx-1200">(A)  </span>teachers  do  not  see  the  symptoms  at  pre-test  so  they  cannot  see  any
improvement  at  post-test,  <span 
class="ecsx-1200">(B)  </span>teachers  see  the  symptoms  at  pre-test  and  do  not  see  any
improvement at post-test. <span 
class="ecsx-1200">(C) </span>Evolution of parents and teachers’ scores between pre and post-test
on studies that satisfy <a 
href="#XCortese2016">Cortese et al.</a>’s inclusion criteria and that provide teachers and parents
scores on the same scale.</span></div><!--tex4ht:label?: x1-240044 -->
                                                                                            
                                                                                            
   </div><hr class="endfigure" />
                                                                                            
                                                                                            
   <h3 class="likesectionHead"><a 
 id="x1-250005"></a>Table captions</h3>
   <div class="table">
                                                                                            
                                                                                            
<!--l. 3--><p class="indent" >   <a 
 id="x1-250011"></a></p><hr class="float" /><div class="float" 
>
                                                                                            
                                                                                            
   <div class="caption" 
><span class="id">Table 1:     </span><span  
class="content">List     of     all     studies     included     in     the     three     diﬀerent     analysis.
<!--l. 7--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>a</mi></mrow></msup 
></math>
Studies   originally   included   in   <a 
href="#XCortese2016">Cortese   et al.</a> [<a 
href="#XCortese2016">2016</a>]   (search   on   August   30,   2015),
<!--l. 7--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>b</mi></mrow></msup 
></math>
studies   satisfying   <a 
href="#XCortese2016">Cortese   et al.</a> [<a 
href="#XCortese2016">2016</a>]’s   criteria   (search   on   December   14,   2017),
<!--l. 7--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>c</mi></mrow></msup 
></math>
studies satisfying <a 
href="#XCortese2016">Cortese et al.</a> [<a 
href="#XCortese2016">2016</a>]’s criteria to the exception of the part relative to the control
group (search on December 14, 2017).</span></div><!--tex4ht:label?: x1-250011 -->
<div class="tabular">
 <table id="TBL-2" class="tabular" 
cellspacing="0" cellpadding="0"  
><colgroup id="TBL-2-1g"><col 
id="TBL-2-1" /><col 
id="TBL-2-2" /><col 
id="TBL-2-3" /><col 
id="TBL-2-4" /><col 
id="TBL-2-5" /><col 
id="TBL-2-6" /></colgroup><tr  
 style="vertical-align:baseline;" id="TBL-2-1-"><td colspan="3" style="text-align:center; white-space:nowrap;" id="TBL-2-1-1"  
class="td11">                                                                                                                                                           <div class="multicolumn"  style="text-align:center; white-space:nowrap;"><span 
class="ecss-0900">Dataset</span></div>                                                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-1-4"  
class="td11">         <span 
class="ecss-0900">Study              </span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-1-5"  
class="td11"><span 
class="ecss-0900">Year</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-1-6"  
class="td11"><!--l. 4--><p class="noindent" ><img 
src="manuscript0x.png" alt="                                                                                                                                                                                                                         SNizFeB ofgrothuep  "  class="pic-halign"  />                                                                                                                                             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-2-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-2-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-2-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-2-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-2-4"  
class="td11">       <a 
href="#XArnold2014"><span 
class="ecss-0900">Arnold et</span><span 
class="ecss-0900"> al.</span></a>          </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-2-5"  
class="td11"><span 
class="ecss-0900">2014</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-2-6"  
class="td11">                                                  <span 
class="ecss-0900">26                                                                             </span></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-3-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-3-1"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-3-2"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-3-3"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-3-4"  
class="td11"> <a 
href="#XBakhshayesh2011"><span 
class="ecss-0900">Bakhshayesh et</span><span 
class="ecss-0900"> al.</span></a> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-3-5"  
class="td11"><span 
class="ecss-0900">2011</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-3-6"  
class="td11"> <span 
class="ecss-0900">18</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-4-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-4-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-4-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-4-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-4-4"  
class="td11"> <a 
href="#XBeauregard2006"><span 
class="ecss-0900">Beauregard and Levesque</span></a>  </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-4-5"  
class="td11"><span 
class="ecss-0900">2006</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-4-6"  
class="td11">                                                  <span 
class="ecss-0900">15                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-5-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-5-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-5-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-5-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-5-4"  
class="td11">       <a 
href="#XBink2014"><span 
class="ecss-0900">Bink et</span><span 
class="ecss-0900"> al.</span></a>           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-5-5"  
class="td11"><span 
class="ecss-0900">2014</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-5-6"  
class="td11">                                                  <span 
class="ecss-0900">45                                                                             </span></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-6-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-6-1"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-6-2"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-6-3"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-6-4"  
class="td11"> <a 
href="#XChristiansen2014"><span 
class="ecss-0900">Christiansen et</span><span 
class="ecss-0900"> al.</span></a> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-6-5"  
class="td11"><span 
class="ecss-0900">2014</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-6-6"  
class="td11"> <span 
class="ecss-0900">14</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-7-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-7-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-7-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-7-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-7-4"  
class="td11">    <a 
href="#XGevensleben2009"><span 
class="ecss-0900">Gevensleben et</span><span 
class="ecss-0900"> al.</span></a>       </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-7-5"  
class="td11"><span 
class="ecss-0900">2009</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-7-6"  
class="td11">                                                  <span 
class="ecss-0900">59                                                                             </span></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-8-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-8-1"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-8-2"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-8-3"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-8-4"  
class="td11"> <a 
href="#XHeinrich2004"><span 
class="ecss-0900">Heinrich et</span><span 
class="ecss-0900"> al.</span></a> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-8-5"  
class="td11"><span 
class="ecss-0900">2004</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-8-6"  
class="td11"> <span 
class="ecss-0900">13</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-9-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-9-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-9-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-9-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-9-4"  
class="td11">     <a 
href="#XHoltmann2009"><span 
class="ecss-0900">Holtmann et</span><span 
class="ecss-0900"> al.</span></a>        </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-9-5"  
class="td11"><span 
class="ecss-0900">2009</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-9-6"  
class="td11">                                                  <span 
class="ecss-0900">20                                                                             </span></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-10-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-10-1"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-10-2"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-10-3"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-10-4"  
class="td11"> <a 
href="#XLinden1996"><span 
class="ecss-0900">Linden et</span><span 
class="ecss-0900"> al.</span></a> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-10-5"  
class="td11"><span 
class="ecss-0900">1996</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-10-6"  
class="td11"> <span 
class="ecss-0900">9</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-11-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-11-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-11-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-11-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-11-4"  
class="td11">      <a 
href="#XMaurizio2014"><span 
class="ecss-0900">Maurizio et</span><span 
class="ecss-0900"> al.</span></a>         </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-11-5"  
class="td11"><span 
class="ecss-0900">2014</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-11-6"  
class="td11">                                                  <span 
class="ecss-0900">13                                                                             </span></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-12-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-12-1"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-12-2"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-12-3"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-12-4"  
class="td11"> <a 
href="#XSteiner2011"><span 
class="ecss-0900">Steiner et</span><span 
class="ecss-0900"> al.</span></a> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-12-5"  
class="td11"><span 
class="ecss-0900">2011</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-12-6"  
class="td11"> <span 
class="ecss-0900">9</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-13-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-13-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-13-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-13-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-13-4"  
class="td11">      <a 
href="#XSteiner2014"><span 
class="ecss-0900">Steiner et</span><span 
class="ecss-0900"> al.</span></a>          </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-13-5"  
class="td11"><span 
class="ecss-0900">2014</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-13-6"  
class="td11">                                                  <span 
class="ecss-0900">34                                                                             </span></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-14-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-14-1"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-14-2"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-14-3"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-14-4"  
class="td11"><a 
href="#XVanDongen2013"><span 
class="ecss-0900">van Dongen-Boomsma et</span><span 
class="ecss-0900"> al.</span></a></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-14-5"  
class="td11"><span 
class="ecss-0900">2013</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-14-6"  
class="td11"> <span 
class="ecss-0900">22</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-15-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-15-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-15-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-15-3"  
class="td11"><!--l. 19--><p class="noindent" ><img 
src="manuscript1x.png" alt="                                                                                                Replicate
                                                                                              Cortese et al.a  "  class="pic-halign"  />                                                                                                                                         </p></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-15-4"  
class="td11">        <span 
class="ecss-0900">13 studies            </span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-15-5"  
class="td11">    </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-15-6"  
class="td11">                                                  <span 
class="ecss-0900">297                                                                            </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-16-"><td colspan="2" style="text-align:center; white-space:nowrap;" id="TBL-2-16-1"  
class="td11">                                                                                                                                                                                               </td><td colspan="3" style="text-align:center; white-space:nowrap;" id="TBL-2-16-3"  
class="td11"></td><!--cmidrule-->
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-17-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-17-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-17-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-17-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-17-4"  
class="td11">     <a 
href="#XBaumeister2016"><span 
class="ecss-0900">Baumeister et</span><span 
class="ecss-0900"> al.</span></a>       </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-17-5"  
class="td11"><span 
class="ecss-0900">2016</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-17-6"  
class="td11">                                                   <span 
class="ecss-0900">8                                                                              </span></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-18-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-18-1"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-18-2"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-18-3"  
class="td11"> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-18-4"  
class="td11"> <a 
href="#XStrehl2017"><span 
class="ecss-0900">Strehl et</span><span 
class="ecss-0900"> al.</span></a> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-18-5"  
class="td11"><span 
class="ecss-0900">2017</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-18-6"  
class="td11"> <span 
class="ecss-0900">72</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-19-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-19-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-19-2"  
class="td11"><!--l. 23--><p class="noindent" ><img 
src="manuscript2x.png" alt="   Update
          b
 Cortese et al.  "  class="pic-halign"  />                                                                                                                                          </p></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-19-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-19-4"  
class="td11">        <span 
class="ecss-0900">15 studies            </span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-19-5"  
class="td11">    </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-19-6"  
class="td11">                                                  <span 
class="ecss-0900">377                                                                            </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-20-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-20-1"  
class="td11">                                                                                                 </td><td colspan="3" style="text-align:center; white-space:nowrap;" id="TBL-2-20-2"  
class="td11"></td><!--cmidrule-->
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-21-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-21-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-21-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-21-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-21-4"  
class="td11">      <a 
href="#XBluschke2016"><span 
class="ecss-0900">Bluschke et</span><span 
class="ecss-0900"> al.</span></a>         </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-21-5"  
class="td11"><span 
class="ecss-0900">2016</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-21-6"  
class="td11">                                                  <span 
class="ecss-0900">19                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-22-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-22-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-22-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-22-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-22-4"  
class="td11">      <a 
href="#XDeilami2016"><span 
class="ecss-0900">Deilami et</span><span 
class="ecss-0900"> al.</span></a>         </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-22-5"  
class="td11"><span 
class="ecss-0900">2016</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-22-6"  
class="td11">                                                  <span 
class="ecss-0900">12                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-23-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-23-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-23-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-23-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-23-4"  
class="td11">     <a 
href="#XDrechsler2007"><span 
class="ecss-0900">Drechsler et</span><span 
class="ecss-0900"> al.</span></a>        </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-23-5"  
class="td11"><span 
class="ecss-0900">2007</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-23-6"  
class="td11">                                                  <span 
class="ecss-0900">17                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-24-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-24-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-24-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-24-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-24-4"  
class="td11">       <a 
href="#XDuric2012"><span 
class="ecss-0900">Duric et</span><span 
class="ecss-0900"> al.</span></a>           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-24-5"  
class="td11"><span 
class="ecss-0900">2012</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-24-6"  
class="td11">                                                  <span 
class="ecss-0900">23                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-25-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-25-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-25-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-25-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-25-4"  
class="td11">      <a 
href="#XEscolano2014"><span 
class="ecss-0900">Escolano et</span><span 
class="ecss-0900"> al.</span></a>         </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-25-5"  
class="td11"><span 
class="ecss-0900">2014</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-25-6"  
class="td11">                                                  <span 
class="ecss-0900">20                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-26-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-26-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-26-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-26-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-26-4"  
class="td11">       <a 
href="#XFuchs2003"><span 
class="ecss-0900">Fuchs et</span><span 
class="ecss-0900"> al.</span></a>           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-26-5"  
class="td11"><span 
class="ecss-0900">2003</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-26-6"  
class="td11">                                                  <span 
class="ecss-0900">22                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-27-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-27-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-27-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-27-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-27-4"  
class="td11">     <a 
href="#XKropotov2005"><span 
class="ecss-0900">Kropotov et</span><span 
class="ecss-0900"> al.</span></a>        </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-27-5"  
class="td11"><span 
class="ecss-0900">2005</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-27-6"  
class="td11">                                                  <span 
class="ecss-0900">86                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-28-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-28-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-28-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-28-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-28-4"  
class="td11">      <a 
href="#XLee2017"><span 
class="ecss-0900">Lee and Jung</span></a>          </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-28-5"  
class="td11"><span 
class="ecss-0900">2017</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-28-6"  
class="td11">                                                  <span 
class="ecss-0900">18                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-29-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-29-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-29-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-29-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-29-4"  
class="td11">       <a 
href="#XLeins2007"><span 
class="ecss-0900">Leins et</span><span 
class="ecss-0900"> al.</span></a>           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-29-5"  
class="td11"><span 
class="ecss-0900">2007</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-29-6"  
class="td11">                                                  <span 
class="ecss-0900">19                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-30-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-30-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-30-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-30-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-30-4"  
class="td11">         <a 
href="#XLi2013"><span 
class="ecss-0900">Li et</span><span 
class="ecss-0900"> al.</span></a>             </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-30-5"  
class="td11"><span 
class="ecss-0900">2013</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-30-6"  
class="td11">                                                  <span 
class="ecss-0900">32                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-31-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-31-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-31-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-31-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-31-4"  
class="td11">       <a 
href="#XMeisel2014"><span 
class="ecss-0900">Meisel et</span><span 
class="ecss-0900"> al.</span></a>          </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-31-5"  
class="td11"><span 
class="ecss-0900">2014</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-31-6"  
class="td11">                                                  <span 
class="ecss-0900">12                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-32-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-32-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-32-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-32-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-32-4"  
class="td11">    <a 
href="#XMohagheghi2017"><span 
class="ecss-0900">Mohagheghi et</span><span 
class="ecss-0900"> al.</span></a>       </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-32-5"  
class="td11"><span 
class="ecss-0900">2017</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-32-6"  
class="td11">                                                  <span 
class="ecss-0900">30                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-33-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-33-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-33-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-33-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-33-4"  
class="td11">    <a 
href="#XMohammadi2015"><span 
class="ecss-0900">Mohammadi et</span><span 
class="ecss-0900"> al.</span></a>      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-33-5"  
class="td11"><span 
class="ecss-0900">2015</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-33-6"  
class="td11">                                                  <span 
class="ecss-0900">16                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-34-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-34-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-34-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-34-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-34-4"  
class="td11">     <a 
href="#XMonastra2002"><span 
class="ecss-0900">Monastra et</span><span 
class="ecss-0900"> al.</span></a>        </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-34-5"  
class="td11"><span 
class="ecss-0900">2002</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-34-6"  
class="td11">                                                  <span 
class="ecss-0900">51                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-35-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-35-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-35-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-35-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-35-4"  
class="td11">    <a 
href="#XOgrim2013"><span 
class="ecss-0900">Ogrim and Hestad</span></a>       </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-35-5"  
class="td11"><span 
class="ecss-0900">2013</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-35-6"  
class="td11">                                                  <span 
class="ecss-0900">13                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-36-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-36-1"  
class="td11">                                                                                                           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-36-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-36-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-36-4"  
class="td11">       <a 
href="#XStrehl2006"><span 
class="ecss-0900">Strehl et</span><span 
class="ecss-0900"> al.</span></a>           </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-36-5"  
class="td11"><span 
class="ecss-0900">2006</span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-36-6"  
class="td11">                                                  <span 
class="ecss-0900">23                                                                             </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-37-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-37-1"  
class="td11"><a 
href="#glo:saob"><span 
class="ecss-0900">SAOB</span></a><!--l. 41--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>c</mi></mrow></msup 
></math></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-37-2"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-37-3"  
class="td11">                                                                                                      </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-37-4"  
class="td11">        <span 
class="ecss-0900">31 studies            </span></td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-37-5"  
class="td11">    </td><td  style="text-align:center; white-space:nowrap;" id="TBL-2-37-6"  
class="td11">                                                  <span 
class="ecss-0900">790                                                                            </span></td>

</tr><tr  
 style="vertical-align:baseline;" id="TBL-2-38-"><td  style="text-align:center; white-space:nowrap;" id="TBL-2-38-1"  
class="td11">                                                                                                           </td></tr></table>
</div>
                                                                                            
                                                                                            
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                                            
                                                                                            
<!--l. 12--><p class="indent" >   <a 
 id="x1-250022"></a></p><hr class="float" /><div class="float" 
>
                                                                                            
                                                                                            
 <div class="caption" 
><span class="id">Table 2:  </span><span  
class="content">Comparison  between  <a 
href="#XCortese2016">Cortese  et al.</a> [<a 
href="#XCortese2016">2016</a>]  results  obtained  with  RevMan  [<a 
href="#XRevMan">Cochrane
Collaboration</a>, <a 
href="#XRevMan">2011</a>]  and  those  obtained  with  the  Python  code  with  our  choices  applied
(<!--l. 17--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>a</mi></mrow></msup 
></math>
post-test values for <a 
href="#XArnold2014">Arnold et al.</a> are obtained after 40 sessions of <a 
href="#glo:nfb">NFB</a> and Conners scale is used
for <a 
href="#XSteiner2014">Steiner et al.</a> teachers’ outcomes). <a 
href="#glo:se">SEs</a> and their corresponding p-value (in parenthesis) are
presented. With the Python program, a negative <a 
href="#glo:se">SE</a> is in favor of <a 
href="#glo:nfb">NFB</a> unlike <a 
href="#XCortese2016">Cortese et al.</a>.</span></div><!--tex4ht:label?: x1-250022 -->
<div class="tabular">
 <table id="TBL-3" class="tabular" 
cellspacing="0" cellpadding="0"  
><colgroup id="TBL-3-1g"><col 
id="TBL-3-1" /><col 
id="TBL-3-2" /><col 
id="TBL-3-3" /><col 
id="TBL-3-4" /></colgroup><tr  
 style="vertical-align:baseline;" id="TBL-3-1-"><td colspan="2" style="text-align:center; white-space:nowrap;" id="TBL-3-1-1"  
class="td11">  <div class="multicolumn"  style="text-align:center; white-space:nowrap;"> Working hsypothesis</div>  </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-1-3"  
class="td11">                                        <!--l. 4--><p class="noindent" ><img 
src="manuscript3x.png" alt="     Same  as
Cortese et al. [2016]  "  class="pic-halign"  />                                                                                                                                                                </p></td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-1-4"  
class="td11">                                    Our choices<!--l. 4--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>a</mi></mrow></msup 
></math>                                                                  </td>

</tr><tr  
 style="vertical-align:baseline;" id="TBL-3-2-"><td  style="text-align:center; white-space:nowrap;" id="TBL-3-2-1"  
class="td11"> <div class="multirow"><!-- rows=0 -->
 <span 
class="ecsi-1200">Parents</span> </div> </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-2-2"  
class="td11">   Total     </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-2-3"  
class="td11"><!--l. 6--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>3</mn><mn>5</mn></math> (<!--l. 6--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>0</mn><mn>0</mn><mn>4</mn></math>)</td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-2-4"  
class="td11"><!--l. 6--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mo 
class="MathClass-bin">−</mo> <mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>3</mn><mn>2</mn></math> (<!--l. 6--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>0</mn><mn>1</mn><mn>3</mn></math>)</td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-3-3-"><td  style="text-align:center; white-space:nowrap;" id="TBL-3-3-1"  
class="td11">        </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-3-2"  
class="td11"> Inattention </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-3-3"  
class="td11"><!--l. 7--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>3</mn><mn>6</mn></math> (<!--l. 7--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>0</mn><mn>0</mn><mn>9</mn></math>)</td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-3-4"  
class="td11"><!--l. 7--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mo 
class="MathClass-bin">−</mo> <mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>3</mn><mn>1</mn></math> (<!--l. 7--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>0</mn><mn>3</mn><mn>6</mn></math>)</td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-3-4-"><td  style="text-align:center; white-space:nowrap;" id="TBL-3-4-1"  
class="td11">        </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-4-2"  
class="td11">Hyperactivity</td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-4-3"  
class="td11"><!--l. 8--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>2</mn><mn>6</mn></math> (<!--l. 8--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>0</mn><mn>0</mn><mn>4</mn></math>)</td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-4-4"  
class="td11"><!--l. 8--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mo 
class="MathClass-bin">−</mo> <mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>2</mn><mn>4</mn></math> (<!--l. 8--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>0</mn><mn>2</mn></math>)</td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-3-5-"><td  style="text-align:center; white-space:nowrap;" id="TBL-3-5-1"  
class="td11"><div class="multirow"><!-- rows=0 -->
 <span 
class="ecsi-1200">Teachers</span> </div></td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-5-2"  
class="td11">   Total     </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-5-3"  
class="td11"><!--l. 9--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>1</mn><mn>5</mn></math> (<!--l. 9--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>2</mn><mn>0</mn></math>)</td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-5-4"  
class="td11"><!--l. 9--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mo 
class="MathClass-bin">−</mo> <mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>1</mn><mn>1</mn></math> (<!--l. 9--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>3</mn><mn>7</mn></math>)</td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-3-6-"><td  style="text-align:center; white-space:nowrap;" id="TBL-3-6-1"  
class="td11">        </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-6-2"  
class="td11"> Inattention </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-6-3"  
class="td11"><!--l. 10--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>0</mn><mn>6</mn></math> (<!--l. 10--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>7</mn><mn>0</mn></math>)</td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-6-4"  
class="td11"><!--l. 10--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mo 
class="MathClass-bin">−</mo> <mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>1</mn><mn>7</mn></math> (<!--l. 10--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>1</mn><mn>6</mn></math>)</td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-3-7-"><td  style="text-align:center; white-space:nowrap;" id="TBL-3-7-1"  
class="td11">        </td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-7-2"  
class="td11">Hyperactivity</td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-7-3"  
class="td11"><!--l. 11--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>1</mn><mn>7</mn></math> (<!--l. 11--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>1</mn><mn>3</mn></math>)</td><td  style="text-align:center; white-space:nowrap;" id="TBL-3-7-4"  
class="td11"><!--l. 11--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mo 
class="MathClass-bin">−</mo> <mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>0</mn><mn>2</mn><mn>2</mn></math> (<!--l. 11--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><mn>0</mn><mo 
class="MathClass-punc">.</mo><mn>8</mn><mn>5</mn></math>)</td>

</tr><tr  
 style="vertical-align:baseline;" id="TBL-3-8-"><td  style="text-align:center; white-space:nowrap;" id="TBL-3-8-1"  
class="td11">        </td></tr></table>
</div>
                                                                                            
                                                                                            
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                                            
                                                                                            
<!--l. 22--><p class="indent" >   <a 
 id="x1-250033"></a></p><hr class="float" /><div class="float" 
>
                                                                                            
                                                                                            
  <div class="caption" 
><span class="id">Table 3:   </span><span  
class="content">Results   of   the   <a 
href="#glo:wls">WLS</a>,   <a 
href="#glo:lasso">LASSO</a>   and   decision   tree.   For   the   <a 
href="#glo:wls">WLS</a>,   a   p-value
<!--l. 26--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" > <mo 
class="MathClass-rel">&#x003C;</mo></math>
0.05 (in bold) means that the coeﬃcient of the corresponding factor is signiﬁcantly diﬀerent from
0. For the <a 
href="#glo:lasso">LASSO</a>, factors not set to 0 (in bold) are selected. For the decision tree, the place of the
factor in the tree is precised. When the value of the coeﬃcient is negative, the corresponding factor
may lead to better <a 
href="#glo:nfb">NFB</a> results.</span></div><!--tex4ht:label?: x1-250033 -->
<div class="center" 
>
<!--l. 1--><p class="noindent" >
</p>
                                                                                            
                                                                                            
<div class="tabular">
 <table id="TBL-4" class="tabular" 
cellspacing="0" cellpadding="0"  
><colgroup id="TBL-4-1g"><col 
id="TBL-4-1" /><col 
id="TBL-4-2" /><col 
id="TBL-4-3" /><col 
id="TBL-4-4" /><col 
id="TBL-4-5" /><col 
id="TBL-4-6" /></colgroup><tr  
 style="vertical-align:baseline;" id="TBL-4-1-"><td colspan="2" style="text-align:center; white-space:nowrap;" id="TBL-4-1-1"  
class="td11"><div class="multicolumn"  style="text-align:center; white-space:nowrap;"> <img 
src="manuscript4x.png" alt="   Independent

variables (factors)  "  class="pic-halign"  />                                                                                                    </div></td><td  style="text-align:left;" id="TBL-4-1-3"  
class="td11"><!--l. 4--><p class="noindent" ></p><!--l. 4--><p class="noindent" ><img 
src="manuscript5x.png" alt="  Coeﬃcients
found by WLS

   (p-value)  "  class="pic-halign"  />  </p></td><td  style="text-align:left;" id="TBL-4-1-4"  
class="td11"><!--l. 4--><p class="noindent" ></p><!--l. 4--><p class="noindent" ><img 
src="manuscript6x.png" alt="                  Coe ﬃcients
                   found by
                    LASSO"  class="pic-halign"  /></p></td><td  style="text-align:left;" id="TBL-4-1-5"  
class="td11"><!--l. 4--><p class="noindent" ></p><!--l. 4--><p class="noindent" ><img 
src="manuscript7x.png" alt="                                 Place
                                on the
                               Decision
                                 Tree  "  class="pic-halign"  />  </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-2-"><td  style="text-align:left;" id="TBL-4-2-1"  
class="td11"><!--l. 6--><p class="noindent" ><div class="multirow"><!-- rows=0 -->
 <span 
class="ecsi-1200">Signal quality</span> </div>   </p></td><td  style="text-align:left;" id="TBL-4-2-2"  
class="td11"><!--l. 6--><p class="noindent" ><a 
href="#glo:eog">Electro-Oculogram
(EOG)</a> correction                                                                                </p></td><td  style="text-align:left;" id="TBL-4-2-3"  
class="td11"><!--l. 6--><p class="noindent" > -0.078 (0.42)    </p></td><td  style="text-align:left;" id="TBL-4-2-4"  
class="td11"><!--l. 6--><p class="noindent" > 0.00       </p></td><td  style="text-align:left;" id="TBL-4-2-5"  
class="td11"><!--l. 6--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-3-"><td  style="text-align:left;" id="TBL-4-3-1"  
class="td11"><!--l. 7--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-3-2"  
class="td11"><!--l. 7--><p class="noindent" >artifact
correction   based
on amplitude                                                                                     </p></td><td  style="text-align:left;" id="TBL-4-3-3"  
class="td11"><!--l. 7--><p class="noindent" > <span 
class="ecsx-1200">0.15(0.040)</span>   </p></td><td  style="text-align:left;" id="TBL-4-3-4"  
class="td11"><!--l. 7--><p class="noindent" > <span 
class="ecsx-1200">0.049</span>    </p></td><td  style="text-align:left;" id="TBL-4-3-5"  
class="td11"><!--l. 7--><p class="noindent" >/             </p></td>

</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-4-"><td  style="text-align:left;" id="TBL-4-4-1"  
class="td11"><!--l. 9--><p class="noindent" ><div class="multirow"><!-- rows=0 -->
 <span 
class="ecsi-1200">Methodological</span> </div></p></td><td  style="text-align:left;" id="TBL-4-4-2"  
class="td11"><!--l. 9--><p class="noindent" ><a 
href="#glo:pblind">PBLIND</a>                                                                                           </p></td><td  style="text-align:left;" id="TBL-4-4-3"  
class="td11"><!--l. 9--><p class="noindent" > <span 
class="ecsx-1200">0.10 (0.043)</span>  </p></td><td  style="text-align:left;" id="TBL-4-4-4"  
class="td11"><!--l. 9--><p class="noindent" > <span 
class="ecsx-1200">0.11</span>     </p></td><td  style="text-align:left;" id="TBL-4-4-5"  
class="td11"><!--l. 9--><p class="noindent" ><span 
class="ecsx-1200">root node</span></p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-5-"><td  style="text-align:left;" id="TBL-4-5-1"  
class="td11"><!--l. 10--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-5-2"  
class="td11"><!--l. 10--><p class="noindent" >randomization                                                                                    </p></td><td  style="text-align:left;" id="TBL-4-5-3"  
class="td11"><!--l. 10--><p class="noindent" > 0.0069 (0.92)   </p></td><td  style="text-align:left;" id="TBL-4-5-4"  
class="td11"><!--l. 10--><p class="noindent" > <span 
class="ecsx-1200">0.033</span>    </p></td><td  style="text-align:left;" id="TBL-4-5-5"  
class="td11"><!--l. 10--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-6-"><td  style="text-align:left;" id="TBL-4-6-1"  
class="td11"><!--l. 11--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-6-2"  
class="td11"><!--l. 11--><p class="noindent" ><a 
href="#glo:irb">IRB</a>                                                                                                 </p></td><td  style="text-align:left;" id="TBL-4-6-3"  
class="td11"><!--l. 11--><p class="noindent" > <span 
class="ecsx-1200">-0.29 (0.00)</span>   </p></td><td  style="text-align:left;" id="TBL-4-6-4"  
class="td11"><!--l. 11--><p class="noindent" > <span 
class="ecsx-1200">-0.15</span>     </p></td><td  style="text-align:left;" id="TBL-4-6-5"  
class="td11"><!--l. 11--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-7-"><td  style="text-align:left;" id="TBL-4-7-1"  
class="td11"><!--l. 13--><p class="noindent" ><div class="multirow"><!-- rows=0 -->
 <span 
class="ecsi-1200">Population</span> </div>      </p></td><td  style="text-align:left;" id="TBL-4-7-2"  
class="td11"><!--l. 13--><p class="noindent" >age max                                                                                           </p></td><td  style="text-align:left;" id="TBL-4-7-3"  
class="td11"><!--l. 13--><p class="noindent" > -0.090 (0.16)    </p></td><td  style="text-align:left;" id="TBL-4-7-4"  
class="td11"><!--l. 13--><p class="noindent" > 0.00       </p></td><td  style="text-align:left;" id="TBL-4-7-5"  
class="td11"><!--l. 13--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-8-"><td  style="text-align:left;" id="TBL-4-8-1"  
class="td11"><!--l. 14--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-8-2"  
class="td11"><!--l. 14--><p class="noindent" >age min                                                                                            </p></td><td  style="text-align:left;" id="TBL-4-8-3"  
class="td11"><!--l. 14--><p class="noindent" > -0.055 (0.37)    </p></td><td  style="text-align:left;" id="TBL-4-8-4"  
class="td11"><!--l. 14--><p class="noindent" > 0.00       </p></td><td  style="text-align:left;" id="TBL-4-8-5"  
class="td11"><!--l. 14--><p class="noindent" ><span 
class="ecsx-1200">2</span><!--l. 14--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>n</mi><mi 
>d</mi></mrow></msup 
></math>
<span 
class="ecsx-1200">and</span>
<span 
class="ecsx-1200">4</span><!--l. 14--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>t</mi><mi 
>h</mi></mrow></msup 
></math>
<span 
class="ecsx-1200">nodes</span>     </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-9-"><td  style="text-align:left;" id="TBL-4-9-1"  
class="td11"><!--l. 15--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-9-2"  
class="td11"><!--l. 15--><p class="noindent" >on drugs                                                                                           </p></td><td  style="text-align:left;" id="TBL-4-9-3"  
class="td11"><!--l. 15--><p class="noindent" > 0.069 (0.42)    </p></td><td  style="text-align:left;" id="TBL-4-9-4"  
class="td11"><!--l. 15--><p class="noindent" > <span 
class="ecsx-1200">0.033</span>    </p></td><td  style="text-align:left;" id="TBL-4-9-5"  
class="td11"><!--l. 15--><p class="noindent" >/             </p></td>

</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-10-"><td  style="text-align:left;" id="TBL-4-10-1"  
class="td11"></p><!--l. 17--><p class="noindent" ><div class="multirow"><!-- rows=0 -->
 <!--l. 17--><p class="noindent" ><img 
src="manuscript8x.png" alt="     NFB
implementation "  class="pic-halign"  />     </div> </p> </td><td  style="text-align:left;" id="TBL-4-10-2"  
class="td11"><!--l. 17--><p class="noindent" >number          of
sessions                                                                                            </p></td><td  style="text-align:left;" id="TBL-4-10-3"  
class="td11"><!--l. 17--><p class="noindent" > -0.0075 (0.92)  </p></td><td  style="text-align:left;" id="TBL-4-10-4"  
class="td11"><!--l. 17--><p class="noindent" > 0.00       </p></td><td  style="text-align:left;" id="TBL-4-10-5"  
class="td11"><!--l. 17--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-11-"><td  style="text-align:left;" id="TBL-4-11-1"  
class="td11"><!--l. 18--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-11-2"  
class="td11"><!--l. 18--><p class="noindent" >session length                                                                                    </p></td><td  style="text-align:left;" id="TBL-4-11-3"  
class="td11"><!--l. 18--><p class="noindent" > 0.17 (0.17)      </p></td><td  style="text-align:left;" id="TBL-4-11-4"  
class="td11"><!--l. 18--><p class="noindent" > 0.00       </p></td><td  style="text-align:left;" id="TBL-4-11-5"  
class="td11"><!--l. 18--><p class="noindent" ><span 
class="ecsx-1200">3</span><!--l. 18--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>r</mi><mi 
>d</mi></mrow></msup 
></math>
<span 
class="ecsx-1200">node</span>       </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-12-"><td  style="text-align:left;" id="TBL-4-12-1"  
class="td11"><!--l. 19--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-12-2"  
class="td11"><!--l. 19--><p class="noindent" >treatment length                                                                                 </p></td><td  style="text-align:left;" id="TBL-4-12-3"  
class="td11"><!--l. 19--><p class="noindent" > <span 
class="ecsx-1200">0.57 (0.00)</span>   </p></td><td  style="text-align:left;" id="TBL-4-12-4"  
class="td11"><!--l. 19--><p class="noindent" > <span 
class="ecsx-1200">0.34</span>     </p></td><td  style="text-align:left;" id="TBL-4-12-5"  
class="td11"><!--l. 19--><p class="noindent" ><span 
class="ecsx-1200">2</span><!--l. 19--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>n</mi><mi 
>d</mi></mrow></msup 
></math>
<span 
class="ecsx-1200">node</span>       </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-13-"><td  style="text-align:left;" id="TBL-4-13-1"  
class="td11"><!--l. 20--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-13-2"  
class="td11"><!--l. 20--><p class="noindent" >session pace                                                                                      </p></td><td  style="text-align:left;" id="TBL-4-13-3"  
class="td11"><!--l. 20--><p class="noindent" > <span 
class="ecsx-1200">-0.25 (0.00)</span>   </p></td><td  style="text-align:left;" id="TBL-4-13-4"  
class="td11"><!--l. 20--><p class="noindent" > <span 
class="ecsx-1200">-0.14</span>     </p></td><td  style="text-align:left;" id="TBL-4-13-5"  
class="td11"><!--l. 20--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-14-"><td  style="text-align:left;" id="TBL-4-14-1"  
class="td11"><!--l. 21--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-14-2"  
class="td11"><!--l. 21--><p class="noindent" ><a 
href="#glo:smr">SMR</a>                                                                                               </p></td><td  style="text-align:left;" id="TBL-4-14-3"  
class="td11"><!--l. 21--><p class="noindent" > -0.063 (0.41)    </p></td><td  style="text-align:left;" id="TBL-4-14-4"  
class="td11"><!--l. 21--><p class="noindent" > <span 
class="ecsx-1200">0.063</span>    </p></td><td  style="text-align:left;" id="TBL-4-14-5"  
class="td11"><!--l. 21--><p class="noindent" ><span 
class="ecsx-1200">3</span><!--l. 21--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>r</mi><mi 
>d</mi></mrow></msup 
></math>
<span 
class="ecsx-1200">node</span>       </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-15-"><td  style="text-align:left;" id="TBL-4-15-1"  
class="td11"><!--l. 22--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-15-2"  
class="td11"><!--l. 22--><p class="noindent" >beta up central                                                                                   </p></td><td  style="text-align:left;" id="TBL-4-15-3"  
class="td11"><!--l. 22--><p class="noindent" > -0.027 (0.72)    </p></td><td  style="text-align:left;" id="TBL-4-15-4"  
class="td11"><!--l. 22--><p class="noindent" > 0.00       </p></td><td  style="text-align:left;" id="TBL-4-15-5"  
class="td11"><!--l. 22--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-16-"><td  style="text-align:left;" id="TBL-4-16-1"  
class="td11"><!--l. 23--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-16-2"  
class="td11"><!--l. 23--><p class="noindent" >theta down                                                                                        </p></td><td  style="text-align:left;" id="TBL-4-16-3"  
class="td11"><!--l. 23--><p class="noindent" > <span 
class="ecsx-1200">-0.29 (0.014)</span> </p></td><td  style="text-align:left;" id="TBL-4-16-4"  
class="td11"><!--l. 23--><p class="noindent" > <span 
class="ecsx-1200">-0.055</span>    </p></td><td  style="text-align:left;" id="TBL-4-16-5"  
class="td11"><!--l. 23--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-17-"><td  style="text-align:left;" id="TBL-4-17-1"  
class="td11"><!--l. 24--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-17-2"  
class="td11"><!--l. 24--><p class="noindent" ><a 
href="#glo:scp">SCP</a>                                                                                                </p></td><td  style="text-align:left;" id="TBL-4-17-3"  
class="td11"><!--l. 24--><p class="noindent" > -0.099 (0.50)    </p></td><td  style="text-align:left;" id="TBL-4-17-4"  
class="td11"><!--l. 24--><p class="noindent" > <span 
class="ecsx-1200">0.10</span>     </p></td><td  style="text-align:left;" id="TBL-4-17-5"  
class="td11"><!--l. 24--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-18-"><td  style="text-align:left;" id="TBL-4-18-1"  
class="td11"><!--l. 25--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-18-2"  
class="td11"><!--l. 25--><p class="noindent" >transfer phase                                                                                    </p></td><td  style="text-align:left;" id="TBL-4-18-3"  
class="td11"><!--l. 25--><p class="noindent" > <span 
class="ecsx-1200">0.27 (0.032)</span>  </p></td><td  style="text-align:left;" id="TBL-4-18-4"  
class="td11"><!--l. 25--><p class="noindent" > <span 
class="ecsx-1200">0.12</span>     </p></td><td  style="text-align:left;" id="TBL-4-18-5"  
class="td11"><!--l. 25--><p class="noindent" >/             </p></td>

</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-19-"><td  style="text-align:left;" id="TBL-4-19-1"  
class="td11"></p><!--l. 27--><p class="noindent" ><div class="multirow"><!-- rows=0 -->
 <!--l. 27--><p class="noindent" ><img 
src="manuscript9x.png" alt="Quality of
acquisition "  class="pic-halign"  />           </div> </p> </td><td  style="text-align:left;" id="TBL-4-19-2"  
class="td11"><!--l. 27--><p class="noindent" >more   than   one
active electrode                                                                                  </p></td><td  style="text-align:left;" id="TBL-4-19-3"  
class="td11"><!--l. 27--><p class="noindent" > 0.064 (0.37)    </p></td><td  style="text-align:left;" id="TBL-4-19-4"  
class="td11"><!--l. 27--><p class="noindent" > 0.00       </p></td><td  style="text-align:left;" id="TBL-4-19-5"  
class="td11"><!--l. 27--><p class="noindent" >/             </p></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-20-"><td  style="text-align:left;" id="TBL-4-20-1"  
class="td11"><!--l. 28--><p class="noindent" >              </p></td><td  style="text-align:left;" id="TBL-4-20-2"  
class="td11"><!--l. 28--><p class="noindent" ><a 
href="#glo:eeg">EEG</a> quality 2                                                                                    </p></td><td  style="text-align:left;" id="TBL-4-20-3"  
class="td11"><!--l. 28--><p class="noindent" > <span 
class="ecsx-1200">-0.36 (0.00)</span>   </p></td><td  style="text-align:left;" id="TBL-4-20-4"  
class="td11"><!--l. 28--><p class="noindent" > <span 
class="ecsx-1200">-0.24</span>     </p></td><td  style="text-align:left;" id="TBL-4-20-5"  
class="td11"><!--l. 28--><p class="noindent" ><span 
class="ecsx-1200">3</span><!--l. 28--><math 
 xmlns="http://www.w3.org/1998/Math/MathML"  
display="inline" ><msup><mrow 
></mrow><mrow 
><mi 
>r</mi><mi 
>d</mi></mrow></msup 
></math>
<span 
class="ecsx-1200">node</span>       </p></td>

</tr><tr  
 style="vertical-align:baseline;" id="TBL-4-21-"><td  style="text-align:left;" id="TBL-4-21-1"  
class="td11">              </td></tr></table>
</div></div>
                                                                                            
                                                                                            
   </div><hr class="endfloat" />
   </div>
    
</body> 
</html>
                                                                                            
                                                                                            
                                                                                            


